Trypanosoma cruzi in mice | studies on resistance and effects of acute infection on the immune response by Reed, Steven Gregory
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
1977 
Trypanosoma cruzi in mice | studies on resistance and effects of 
acute infection on the immune response 
Steven Gregory Reed 
The University of Montana 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
Let us know how access to this document benefits you. 
Recommended Citation 
Reed, Steven Gregory, "Trypanosoma cruzi in mice | studies on resistance and effects of acute infection 
on the immune response" (1977). Graduate Student Theses, Dissertations, & Professional Papers. 3957. 
https://scholarworks.umt.edu/etd/3957 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
TRYPANOSOMA CRUZI IN MICE. 
STUDIES ON RESISTANCE AND EFFECTS 
OF ACUTE INFECTION ON THE IMI4UNE RESPONSE* 
by 
Steven G. Reed 
B. A., Whitman College, 1973 
Presented in partial fulfillment of the requirements 
for the degree of 
MASTER OF SCIENCE 
UNIVERSITY OF MONTANA 
1977 
Chairman, Board of Examiners 
p^kh, Graduate Schbol 
Date / / 
UMI Number: EP34706 
All rights reserved 
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent on the quality of the copy submitted. 
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed, 
a note will indicate the deletion. 
UMT 
DlMjrtalion PuMkNng 
UMI EP34706 
Copyright 2012 by ProQuest LLC. 
All rights reserved. This edition of the work is protected against 
unauthorized copying under Title 17, United States Code. 
ProQuesf 
ProQuest LLC. 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
Reed, Steven G., M. S., March 1977 Microbiology 
Trypanosoma cruzi in Mice. Studies on Resistance and 
Effects of Acute Infection on the Immune Response. 
(132 pp) 
Director: Carl L. Larson C-W-
Specific immunization with live attenuated trypanosomes 
and stimulation of non-specific resistance by viable 
Mycobacterium tuberculosis strain BCG were used to examine 
mechanisms of induced immunity against Chagas' disease 
in mice. In addition, the effects of acute infection 
on the immune response of mice to antigens unrelated 
to the trypanosomes were observed. 
Resistance to T. cruzi in mice appears to be cell-
mediated and to require specific activation of the immune 
system. BCG alone did not protect against acute infection 
but live attenuated trypanosomes did if given at least 
12-14 days in advance of challenge. Killed trypanosomes 
were not protective. Administration of silica, a macro­
phage toxin, prior to challenge exacerbated infection. 
Activation of the immune system with BCG actually 
interfered with the induction of specific resistance 
by attenuated trypanosomes. 
Mice lost their ability to mount an immune response to 
other antigens during the period of acute infection. 
Suppression of humoral and cellular responses occurred 
during the stages of marked parasitemia. Infected mice 
unable to respond to oxazolone could confer sensitivity 
to this substance via spleen cell transfer. The ability 
of infected mice to respond to oxazolone was significantly 
improved when they received syngeneic macrophages at the 
time of skin test. 
Mice became increasingly susceptible to bacterial 
endotoxin as the infection progressed, also suggesting 
impairment of their immune response. 
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Chapter 1 
INTRODUCTION 
Classification of Trypanosoma cruzi 
Hoare, 1966 
Phylum PROTOZOA Goldfuss, 1818; emend. Siebold, 1845 
Subphylum SARCOMASTIGOPHORA Honigberg and Balamuth, 1963 
Superclass MASTIGOPHORA Diesing, 1866 
Class ZOOMASTIGOPHORMA Calkins, 1909 
Order KINETOPLASTIDA Honigberg, 1963 
Suborder TRYPANOSOMATINA Kent, 1880 
Family TRYPANOSOMATIDAE Doflein, 1901; 
emend. Grobben, 1905 
Genus TRYPANOSOMA Gruby, 184 3 
Species CRUZI Chagas, 1909 
General 
Chagas' disease, or American trypanosomiasis, is the 
result of infection with Trypanosoma (Schizotrypanum) cruzi, 
a protozoan parasite of man and many other mammals. It is 
an extremely important public health problem in many Ibero-
American countries. The disease is widely distributed, 
occurring in portions of the southern United States and most 
of the South American countries. An estimated seven million 
persons are believed to harbor the parasite (41) and the 
mortality rate is high, especially among young children. It 
is most often a severe chronic infection leading to 
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debilitation of the victim through a variety of path­
ological changes. 
The disease is transmitted by many species of reduviid 
bugs (subfamily Triatominae), also known as cone-nosed or 
kissing bugs. In Latin America, they are known popularly 
as barbeiros, hitas, pitos, or vinchucas. These blood­
sucking insects feed at night and defecate immediately 
after feeding. The excreta contains the infective stages 
of the parasite, which have completed the final stages of 
development in the digestive tract of the bug. Contamina­
tion of the mucous membrane of the eye or of the wound 
made by the bite leads to infection. This method of 
transmission is referred to as posterior station. The main 
reservoirs of the disease appear to be armadillos and 
opossums, but many other terrestrial mammals are infected. 
Other means by which humans may become infected include 
blood transfusion and transplacental passage. 
Trypanosoma cruzi has two main stages in its life 
cycle. One takes place in man or a reservoir host, and 
the other in the insect vector. The parasite is pleo­
morphic, occurring in different forms during the course 
of its life cycle. The insect ingests the trypanosomes 
with a blood meal, and the insect forms develop to the 
infective forms found in the feces. The parasites, having 
gained entrance into a suitable host, multiply rapidly at 
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the site of infection and a local inflammatory reaction 
ensues. This consists of cellular infiltration character­
istic of a local inflammation, with both polymorphonuclear 
and mononuclear phagocytes present. The regional lymph 
nodes become enlarged. After a brief incubation period the 
organism enters the blood stream and initiates the acute 
phase of Chagas' disease. The organism will not divide 
in the blood stream, but does so only within cells which 
either engulf the parasite or are invaded by the organism. 
Some strains have greater affinity for muscle tissue, 
especially cardiac, while others preferentially invade 
nervous or reticuloendothelial tissue. Most strains 
divide readily within host macrophages (6, 91). Char­
acteristic features of this phase of Chagas' disease in­
clude splenomegaly and hepatomegaly, generalized adeno­
pathy, and fever. Parasites are readily isolated from the 
blood during the acute phase. If the host survives, the 
chronic phase is initiated, which is characterized by few 
circulating trypanosomes and progressive tissue destruc­
tion by the intracellular forms. The chronic phase may 
extend for a period of many years but spontaneous recovery 
may occur. Death often results from severe damage to the 
heart, or from the destruction of nerve plexi responsible 
for maintaining muscle tone in the alimentary canal lead­
ing to megacolon or megaesophagus. When few circulating 
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parasites are present, diagnosis may be made by hemoculture 
or by xenodiagnosis. The latter is a procedure utilizing 
a non-infected vector which is allowed to feed on the 
patient and is subsequently examined for the presence of 
parasites. Trypanosoma cruzi is the only major pathogen 
of the Stercoraria group of trypanosomes. 
History 
Accounts of a disease, "Bicho", peculiar to the area 
of the natural distribution of the reduviid bugs began to 
appear in American chronicles as early as the 16th century. 
The disease was described as having a long and chronic 
course, with a characteristic feature of rectal distension 
(34). Infestation of the diseased rectum by worms led the 
early observers to believe the disease was caused by hel­
minthic infection, and they named it "Mai de Culo" in 
Spanish, or "Maculo" in Portuguese. This means simply 
disease of the colon. Later reports referred to "Mai de 
Engasgo", or megaesophagus, as being a serious disease in 
Brasil. A common treatment was to apply juice from the 
tobacco leaf to the affected area. 
Observations of the reduviid vectors were recorded 
long before the identification of the parasite. A passage 
from Charles Darwin (1809 - 1882) describing his encounter 
with the insects appeared in the "Journal of researches 
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into... various countries visited by H. M. S. Beagle", 
London, 1839 (after Guerra, 1970). 
(1839 ed., pp. 403-404) "... At night I experienced 
an attack (for it deserves no less a name) of the 'Benchuca' 
(species of Reduvius) the great black bug of the Pampas. 
It is most disgusting to feel soft wingless insects, about 
one inch long, crawling over one's body. Before sucking 
they are quite thin, but afterwards become round and bloated 
with blood, and in this state they are easily crushed. 
They are also found in the northern parts of Chile and in 
Peru. One which I caught at Iquiques was very empty. When 
placed on the table, and though surrounded by people, if a 
finger was presented, the bold insect would immediately 
draw its sucker, make a charge, and if allowed, draw blood. 
No pain was caused by the wound. It was curious to watch 
its body during the act of sucking, as it changed in less 
than ten minutes, from being as flat as a wafer to a globu­
lar form. This one feast, for which the 'Benchuca* was 
indebted to one of the officers, kept it fat during four 
whole months; but, after the first fortnight, the insect 
was quite ready to have another suck." This account is 
especially interesting, for it is generally agreed that 
Darwin contracted Chagas' disease on this expedition, and 
suffered from the infection, until his death some forty 
years later (57) . 
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In 1907, Carlos Chagas, a young medical officer, was 
assigned to investigate measures to be taken to safeguard 
the health of railroad workers in the Minas Gérais state 
in the United States of Brasil. The main concern in the 
area was malaria. While investigating local insects, he 
noticed flagellated protozoa in the hindgut of the cone-
nosed bugs. It should be remembered that this was a time 
of great interest in insects and their role as vectors, 
for in 1893, Theobald Smith had associated a tick with 
Texas Cattle Fever (85) . Chagas sent specimens to his 
supervisor, Oswaldo Cruz in Rio de Janeiro. Shortly after 
his initial findings of the organisms in bugs, Chagas 
found them in the blood of monkeys and in a small girl 
suffering from an unknown illness. (It is interesting to 
note that this girl was found to be harboring the parasite 
some sixty years after being examined by Chagas). These 
investigations were followed by numerous findings of the 
parasite in human patients, and it was soon associated with 
a disease known to be prevalent in that area. This is an 
unique example of the identification of an etiological 
agent before that agent was associated with a disease. 
Chagas went on to describe the life cycle of the 
parasite (11, 12) but mistakingly thought the organism 
was passed to mammals directly through the bite of the 
bug (anterior station transmission), and that multiplication 
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occurred in the mammal by a form of schizogony. Hence 
the misnomer Schizotrypanum cruzi. These mistakes con­
cerning the transmission and life cycle of T. cruzi were 
corrected by Brumpt (9). 
Immunity 
The course of infection with T. cruzi is influenced 
by a number of factors. The numerous strains capable of 
causing infection vary greatly in their virulence for 
different hosts. This variation is affected by their 
histotropism, as well as a variety of host factors. Among 
the most virulent strains is the Tulahuen, a reticulo-
tropic strain first isolated in Chile from a human patient. 
This organism shows a special affinity for host macro­
phages (90). As with most virulent strains, the Tulahuen 
shows a preference for a certain tissue but is capable of 
invading and dividing in others. 
Among the host factors influencing the course of the 
disease are age and sex. In general, young males are most 
susceptible to infections. The mortality rate is especial­
ly high in children. 
Natural immunity to Chagas' disease is not uncommon, 
as evident from the large number of asymptomatic carriers. 
Both humoral and cellular immune responses occur in T. cruzi 
infection (64, 65, 72). The acute phase, characterized by 
a progressive rise in parasitemia can be established (61). 
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Both IgM and IgG classes of antibody are present during 
the acute stage (28, 99). 
The role of these antibodies in immunity is not well 
established. Conference of protection by passive transfer 
of immune serum has been generally unsuccessful (19, 38). 
Complement-mediated lysis of culture forms occurs vitro, 
and complement depletion in mice has been reported to 
exacerbate infection (73). Some workers have reported 
passive transfer of protection with immune serum (46) , but 
with most strains of high virulence this is not possible. 
The value of antibodies in protection was supported by 
the observation (52) that mother rats could transfer immu­
nity to their offspring, but in human cases, infants with 
high antibody titers at birth often have severe parasitemia. 
Much of the apparent contradiction of the results concern­
ing protection and antibody in Chagas' disease may be due 
to differences in strains used, and in the interpretation 
of results, since much of the work was done before many of 
the immunological processes were understood. 
To support the view that antibodies are not directly 
responsible for the destruction of T. cruzi in vivo, Pizzi 
put forth the following arguments (41) : a) immunized rats 
can be shown to have high antibody titers but little or no 
protection, b) the serum of immune animals has no effect on 
virulent trypanosomes vitro, c) administration of 
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hyperimmune serum to non-immune animals fails to protect 
them against infection, d) splenectomy does not alter the 
course of infection, and e) newborns with high titers of 
specific antibody may be born with acute parasitemia. 
The importance of cell-mediated immunity in Chagas' 
disease is well established. Delayed skin reactions can 
be demonstrated in immunized and chronically infected 
individuals (95) , and passive transfer of sensitivity to 
T. cruzi antigens can be made using lymphocytes from 
sensitized donors (93) . ^ vitro correlates of cellular 
immunity, such as blast cell transformation and inhibition 
of macrophage migration have also been observed (79, 80, 
81, 95, 107) . 
Immune protection against lethal challenge involves 
cellular immunity, as shown by the passive transfer of 
protection with spleen cells from infected animals (53, 76). 
Animals that have been thymectomized or treated with anti-
thymocyte serum prior to challenge with virulent T. cruzi 
develop higher parasitemias and die more rapidly than do 
normal infected animals (75, 78). 
Animals with acquired immunity mobilize inflammatory 
macrophages when challenged with T. cruzi as do non-immune 
animals, but they do so more rapidly and with higher 
numbers (26). Phagocytosis appears to be very important 
in defense against T. cruzi infection. Some workers (47) 
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have reported enhancement of infection when experimental 
animals were pretreated with silica particles to destroy 
phagocytic cells. Correspondingly, non-specific stimu­
lation of the reticuloendothelial system with diethyl-
stilbesterol or complete Freund's adjuvant reportedly 
enhances resistance when used in the presence of specific 
antigen (3, 49). Non-specific activation of the reticulo­
endothelial system with BCG is not a useful method to 
protect against virulent challenge, however. Although one 
group of investigators has reported achieving non-specific 
resistance using viable BCG (69) , the great majority of 
attempts to immunize with BCG have been unsuccessful 
(4 2, 53). 
The fact that virulent T. cruzi can multiply within 
macrophages suggests that they are generally resistant to 
phagocytic process of these cells. Some vivo studies 
have shown the parasites are destroyed in macrophages of 
immune animals, but survive and multiply in normal macro­
phages (90). This is consistent with the idea of the 
importance of phagocytosis in immune protection against 
Chagas' disease. However, inconsistencies arise from 
studies using BCG-activated macrophages. Hoff (42) has 
shown that macrophages from BCG-immunized animals were 
able to limit parasite multiplication and to resist de­
struction better than normal macrophages when cultured 
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with virulent T. cruzi in vitro » In fact, the macro­
phages from BCG-immunized mice were as resistant as those 
from mice specifically immunized with live avirulent 
T. cruzi. Interestingly, when either of the groups of 
activated macrophages were incubated with immune serum, 
their ability to destroy the parasites was significantly 
increased, strongly suggesting an important role for cyto-
philic antibody. Immune serum did not alter the resistance 
of normal macrophages to T. cruzi. Although BCG-activated 
macrophages were more resistant than normal ones ̂  vitro, 
BCG-immunized mice were not protected against lethal 
challenge, even when the parasites were first incubated 
with immune serum. 
Infection alone, without prior immunization, appears 
to activate the host reticuloendothelial system. Macro­
phages from infected animals spread more on glass than do 
normal cells, and the clearance of colloidal carbon parti­
cles from the bloodstream is more rapid in infected than 
in normal mice (15). 
Immunization 
Further implicating the importance of cell-mediated 
immunity in Chagas' disease is the proven superiority of 
live vaccines to produce protection against virulent in­
fection (60, 106). Animals that survive acute infection 
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are usually resistant to subsequent infection (19, 105). 
In some cases, this is not a sterile immunity, but relies 
on the presence of parasites in the host. This condition 
is known as premunition. 
Protection is often produced experimentally with live 
attenuated trypanosomes. Repeated passage in culture 
media is a useful way to produce organisms of lowered 
virulence (62) . X-irradiated organisms may also be used 
for immunization. The use of live vaccines for prevention 
of Chagas' disease in man is not advocated at this time 
due to the limited information available regarding possible 
reversion of attenuated organisms to the virulent state and 
the potential of producing chronic infection by such vaccines. 
Killed organisms are far less effective immunizing 
agents. In a few instances, incorporation of a killed 
vaccine with an adjuvant provided some degree of resistance 
(44). Methods that kill the organism but leave it intact 
are desirable. Fernandes et al^. (22) were able to protect 
animals against lethal challenge by first incubating the 
organisms with actinomycin D. This procedure left the 
organism motile, but unable to divide due to blockage of 
nucleic acid synthesis. Recently, culture forms killed 
with a mild solution of sodium perchlorate have proven 
effective for immunization of experimental animals (4 9). 
To achieve good protection with killed organisms, multiple 
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doses are usually necessary (106). Animals effectively 
immunized, especially with organisms of low virulence, 
typically demonstrate good cell-mediated responses to 
T. cruzi antigen (27, 79). 
All of the reticuloendothelial organs may undergo 
change during infection, due to the presence of large 
numbers of organisms in macrophages. The most dramatic 
changes occur in the spleen and lymph nodes. In the 
spleen, hyperplastic and degenerative changes occur 
concommitantly. The hyperplasia predominates initially, 
and is followed by degeneration (90) . In general, an 
overall reduction of lymphocytes is seen in spleens of 
severely infected hosts. Macrophages appear activated, 
and are often engorged with parasites and cellular debris. 
As the infection progresses, an increase in the ratio of 
large lymphocytes to small is noted. 
Lymphocyte depletion is also noted in certain areas 
of the lymph node, along with mobilization of reticular 
cells. Whether or not the overall lymphocyte population 
of the nodes declines is doubtful, for intense mitotic 
activity takes place until just before death or recovery 
from the acute phase. This activity predominates through­
out the node, and especially in the B-lymphocyte-rich 
cortical areas. 
In the liver of an infected animal, Kupffer cells 
are often seen to contain many parasites. Acute and 
14 
chronic hepatitis develops, with local inflammatory lésions 
throughout. Although often filled with parasites, the 
Kupffer cells apparently do not lose their ability to 
phagocytose other particles as demonstrated by the increased 
rate of carbon clearance in infected animals. 
Tissue destruction and inflammation occurs in many 
other areas; particularly in muscle, nervous, and gonad 
tissue. The damage is generally caused by invasion and 
multiplication by the parasite, although the possibility 
of damage from toxins may exist {25, 51). Evidence for 
toxic damage stems from observations of destruction of 
uninfected cells. Furthermore, a trypanosomal toxin has 
been postulated to explain inhibitory effects on certain 
malignancies seen in animals with T. cruzi infection 
(36, 37). An extract from cultured T. cruzi is sold 
commercially in Europe under the trade name "Trypanosa" 
for use as an antitumor agent. 
Some workers suggest that a state of allergy is 
produced during infection by sensitization to antigens 
released by degenerated parasites. Muniz and Azevado 
(63) were able to produce lesions of myocarditis in 
monkeys indistinguishable from those seen in Chagas' 
disease by the injection of dead antigens of T. cruzi. 
Some of the pathological changes are due to destruction 
of neurons throughout the peripheral nervous system. 
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Allergie type reactions may have a role in this aspect 
of the pathology. 
Immunosuppression in Protozoal Infections 
An interesting phenomenon associated with certain 
protozoal infections is the suppressive effect these 
infections have on the ability of the host to respond to 
other antigens. This has been observed in malaria, 
leishmaniasis, toxoplasmosis, African trypanosomiasis, 
and Chagas' disease (1, 7, 14, 15, 16, 17, 29, 30, 31, 
32, 39, 66, 77, 98). Affects on both humoral and cellular 
immunity have been noted, though not always in the same 
disease. The mechanisms involved are not understood, 
and appear to be varied and complex. It is probable 
that active infection is necessary for the immunosuppress­
ive effect to occur (59, 109). 
There is evidence for direct lymphocyte involvement, 
since histological aberrations of the spleen and lymph 
nodes appear in animals with malaria, toxoplasmosis, 
Chagas' disease, and African trypanosomiasis (30, 39, 59, 
90). Many of the parasites involved with immunosuppression 
are harbored within blood cells (Toxoplasma, T. cruzi, 
Leishmania, Plasmodium), but others are not (African 
trypanosomes). Many differences in the host-parasite 
relationships involved in these diseases make it difficult 
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to postulate a common mechanism for immunosuppression. 
Possible mechanisms at work in immunosuppression associ­
ated with protozoal infection will be discussed later. 
Interest in this aspect of the infectious process lies 
in a better understanding of the immune system, with 
special reference to cell cooperation. Clinically, 
immunosuppressive effects stemming from such infections 
could predispose patients to other disease. 
Suppression of cell-mediated immunity may be dir­
ected against the afferent or efferent arm of the response. 
Delayed hypersensitivity reactions may be considered to 
occur in two stages: the induction of the response and 
the expression or manifestation of the response. During 
the inductive phase, T-lymphocytes become "primed" by 
the antigen and are stimulated to begin producing clones. 
After sufficient time has elapsed for significant numbers 
of these cells to be produced, the host is able to respond 
to eliciting doses of the sensitizing substance, and 
thus to express delayed hypersensitivity. This stage is 
characterized by a visible reaction at the site of 
injection of specific antigen and the typical cells ob­
served in histological preparations of the lesion. 
When oxazolone, a chemical contact sensitizing agent, 
is applied to the skin, large pyroninophilic cells, termed 
immunoblasts, appear in the lymph node draining the site 
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of application. Expression of the response involves 
induration and erythema at the site of skin test, and an 
abundance of lymphocytes and macrophages in the lesion. 
There is typically a relative paucity of polymorpho­
nuclear leukocytes (97). 
Statement of Problem 
This research was designed.to examine: 1) proce­
dures for immunization against Trypanosoma cruzi and 
2) the effects of acute infection with this parasite on 
the immune system of the host. 
Chapter 2 
MATERIALS AND METHODS 
Animals 
Conventional outbred male Swiss mice, weighing 
30-40 g were used in most experiments. In the passive 
transfer studies, inbred C57B1/10 mice, adult males, 
were used. All mice were obtained from the Rocky 
Mountain Laboratory in Hamilton, Montana, housed in 
plastic cages, and given Purina Lab Chow and water 
ad lib. 
Parasites 
Blood and culture forms of the Tulahûen strain of 
Trypanosoma cruzi were obtained from Dr. Robert G. Yaeger 
(Dept. of Tropical Medicine, Parasitology Division, Tulane 
University, New Orleans, La.). 
Blood forms were maintained by weekly passage of 
whole blood from infected to normal mice. Culture forms 
were maintained in the dialysate media of Nakamura (1967). 
These organisms have been passed in culture more than 
300 times. Dialysate media was chosen to minimize foreign 
proteins in the cultures. Culture forms were used for 
immunization and blood forms for infecting mice. 
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Media 
Powdered MEM (Eagle) with Earle's Salts, L-glutamine, 
and non-essential amino acids was purchased from GIBCO 
(Santa Clara, Ca.) and was reconstituted to 90% of its 
final volume with triple distilled water. Streptomycin 
sulfate and penicillin G were added during preparation to 
final concentrations of 100 pg/ml and 100 U/ml respectively. 
The pH was adjusted to 7.3 with NaOH. The media was 
filter-sterilized before use. 
Determination of the Lethal Dose-fifty (LD^Q) 
Determination of the LD^^ for the Tulahûen strain in 
Swiss and C57B1/10 mice was performed by challenging mice 
with different numbers of blood forms obtained from 
infected mice. Blood was drawn into a heparinized syringe 
by severing the brachial artery of an etherized mouse in 
which the parasitemia was high. Approximately 1.0 ml of 
blood was obtained in this manner from a 30 g mouse. The 
blood was diluted with sterile Locke's solution and the 
trypanosomes were counted with a hemocytometer. The 
parasite suspension was adjusted to concentrations ranging 
from 5 X 10^ to 1 x 10^ parasites/ml and 0.2 ml of each 
concentration was injected into groups of 8 mice each. 
The Swiss mice were injected with various concentrations of 
parasites by intravenous (iv) or intraperitoneal (ip) 
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routes. Deaths were recorded on a daily basis. Sur­
vivors were killed after forty days. 
Immunization Studies 
Adult male conventional Swiss mice were used in this 
and all subsequent experiments with the exception of the 
cell transfer studies. 
BCG vaccine 
Attenuated Mycobacterium bovis, or BCG (bacille 
Calmette-Guérin), was obtained from stock maintained in 
the Stella Duncan Institute. Stock cultures were diluted 
with Dubos broth to an optical density of 200 ("Klett 200") 
on a Klett-Summerson photoelectric colorimeter equipped 
with a blue filter (Klett-Summerson no. 42, spectral range 
400-465nm). These were stored at -70 C and prepared for 
use as follows: After thawing, the stock was diluted to a 
"Klett 100" suspension by adding an equal volume of Dubos 
broth. This was inoculated ip into mice in 0.2 ml volumes. 
To determine the number of colony-forming units (CPU) of 
BCG administered, 3 0.1 ml volumes of 10~^, 10~^, 10~^ 
dilutions were plated on duplicate Dubos agar plates. The 
plates were sealed in plastic bags and incubated at 37 C 
for 28 days. The visible colonies were counted, making it 
possible to calculate the number of viable BCG organisms/ 
dose. This number was found to be 5 x 10^ - 10 x 10^. 
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T. cruzi vaccine 
To prepare trypanosomes for use in immunization, 
dialysate media was inoculated with culture forms of 
T. cruzi and incubated at 28 C for 14-16 days. This was 
sufficient time to achieve prolific growth in media 
seeded with approximately 5 x 10^ organisms/ml. After 
incubation, cultures were centrifuged at 5,000 x g for 
10 minutes and the pellet was resuspended in sterile 
Locke's solution. The parasites were washed 3 times and 
adjusted to a concentration of approximately 1 x 10^/ml. 
Mice injected ip with 0.02 ml of this suspension of live 
trypanosomes 14 and 7 days before challenge with virulent 
blood forms showed transient parasitemias but survived 
infection. 
Effects of specific and non-specific immunization on the 
course of infection with T. cruzi 
Mice were injected ip with various combinations of 
BCG and live attenuated T. cruzi prior to challenge with 
5 LDgQ doses of virulent T. cruzi. The challenge was given 
8 days after the last immunizing dose. An unimmunized 
control group was infected with the same dose at the 
same time. 
Effects of iv immunization with BCG on the course of 
infection with T. cruzi 
Mice were given one or two doses of BCG (0.2 ml of a 
Klett 100 preparation) iv 11 days and 1 day prior to 
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infection. Groups of mice treated in this way were then 
challenged with 2 or 50 doses of T. cruzi. Separate 
groups of unimmunized control mice were infected with 
either of the 2 doses of trypanosomes. In addition, a 
group of mice receiving only a primary dose of BCG, 11 days 
before infection, was challenged with 2 LD^Q doses of 
T. cruzi. Deaths were recorded daily. 
Effects of immunization with live and killed culture forms 
on the course of infection with virulent T. cruzi 
Live attenuated culture forms were administered as 
described previously. Killed parasites were prepared by 
subjecting washed culture forms to 5 cycles of alternate 
freeze-thawing, using an acetone-dry ice bath and a 37 C 
water bath. The organisms were counted before the freeze-
thaw treatment, and equivalent numbers of killed and live 
parasites were used for the immunizations. All injections 
were given ip. 
Effect of Treatment with Silicon Dioxide Particles on the 
Course of Infection with T. cruzi 
Silicon dioxide (SiOg) ("Min-U-Sil, Whittaker, Clark 
and Daniels, N.Y. 5 p) were suspended in sterile phosphate-
buffered saline (PBS) at concentrations of 100, 200, and 
300 mg/ml. Two-tenths of one of the suspension were in­
jected ip into the various groups of mice. Groups of 8 
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mice each were given one of these doses on the day before 
challenge, the day of challenge, or on both days. A control 
group receiving no Si02 was challenged at the same time 
in a similar manner. Deaths were recorded daily. 
Course of Infection with T. cruzi 
Reticuloendothelial clearance of colloidal carbon particles 
in mice infected with T. cruzi (after Stuart, (88) ) 
A solution of colloidal carbon was prepared as follows; 
black ink, "Spezialtusche" (Gunther Wagner, Pelikan Werke, 
Hanover, Germany), in a stock solution of 64 mg carbon/ml 
was diluted in saline to a final concentration of 16 mg/ml. 
The diluting saline contained approximately 0.5% concentra­
tion of gelatin. Normal mice and mice acutely ill with 
Chagas' disease were injected iv with the carbon suspen­
sion using doses of 100 mg/kg body weight. The infected 
animals had received 1 LDr. dose of virulent T. cruzi 
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16 days prior to administration of the carbon. Blood 
samples of approximately 0.05 ml were taken from the retro-
orbital sinus with a heparinized capillary pipette at 
intervals of 2, 6, 10 and 20 minutes after injection of 
the carbon suspension. The size of the blood sample was 
constant at each bleeding. The blood was mixed with 2.0 ml 
distilled water immediately after being drawn and the 
optical density of the suspension was read in a Coleman Jr. 
II, Model 6/35 spectrophotometer at a wavelength of 
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490 nm. Control readings of blood alone from normal arid 
infected mice were also made. 
Changes in spleen weight during the course of infection 
with ,T. cruzi 
Spleens were removed from groups of mice, 5 mice/group, 
3 at various days after ip injection of 1 x 10 blood forms 
of T. cruzi and placed in a beaker containing MEM. 
The spleens were trimmed of foreign tissue, blotted 
dry, and weighed on à top-loading Mettler balance. The 
weights of each group of spleens were averaged. 
Changes in total blood cell count during the course of 
infection with T. cruzi 
The blood of groups of five mice was pooled with a 
small amount (0.5 ml) of heparinized saline at intervals 
of 5, 8, 10, 12, 14 and 16 days after infection with 
1 X 10^ virulent T. cruzi. The total number of red blood 
cells for each group and for an uninfected control group 
were determined with a hemocytometer. 
Similar procedures were used to compare total and 
differential white blood cell counts. 
Course of parasitemia during infection with T. cruzi 
Male Swiss mice were inoculated ip with 1 LD^Q dose 
of T. cruzi blood forms. Groups of mice were exsanguin­
ated every other day following infection, their blood was 
pooled, and parasite counts were made with a hemocytometer. 
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Effect of infection with T. cruzi on the inflammatory 
response 
Groups of 5 normal mice and of mice infected for 
16 days with 1 LD^g dose of T. cruzi blood forms received 
0.05 ml of a 1:5 mixture of turpentine in olive oil sub-
cutaneously (sc) in the right ear and 0.05 ml of saline in 
the left. Difference in thickness between the ears were 
measured with a "Schnelltaster" dial guage micrometer 
after 24 h. 
Tests for Delayed Hypersensitivity (DH) in 
Normal Mice and Mice Infected with T. cruzi 
Oxazolone (4-ethoxymethylene-2-phenyl oxazolone, BDH 
Chemicals, Ltd. Poole, England), a potent skin-sensitizing 
agent, and complete Freund's adjuvant (CFA) were used to 
compare DH responses in normal and infected mice. 
Oxazolone 
One-tenth ml of a freshly prepared 3% (wt/vol) solu­
tion of oxazolone in absolute ethanol was rubbed on the 
pre-shaven abdomen of mice. Seven days after sensitiza­
tion, 1 drop (from a 25 ga. needle) of a 1.5% solution of 
oxazolone in a 1:1 mixture of absolute ethanol and olive 
oil was applied to the inner surface of each ear. The 
thickness of each ear was measured with a "Schnelltaster" 
immediately before applying the solution and again at 24 h. 
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CFA (Complete Freund's Adjuvant) 
Two parts of Arlacel A (Sigma, St. Louis) and 3 mg 
of dried tubercle bacilli were ground together with mortar 
and pestle. Eight parts light mineral oil were added and 
mixed. Ten parts sterile saline, pH 7.0, were added drop-
wise and an even emulsion was obtained. The preparation 
was drawn back and forth between two 10 ml syringes joined 
with a double-hubbed needle. Mice were injected sc with 
0.2 ml of this preparation, which contained 0.1 mg of 
dried tubercle bacilli. 
Fourteen days after immunization with CFA, mice were 
inoculated sc with 12.5 pg of BCG protoplasm suspended in 
0.05 ml saline in one footpad. The other footpad was 
injected with the same volume of saline. After 24 h, the 
thickness of each footpad was measured with a "Schnell-
taster" and the differences in measurements were recorded. 
The response was expressed as the thickness of the foot­
pad injected with the protoplasm minus that of the foot­
pad injected with saline only. 
Mice were sensitized with 1 of these antigens at 
various times before or during injection and subsequently 
skin tested. The responses were compared to those of 
uninfected animals. 
The ability of mice to either develop or express 
sensitivity to oxazolone was tested. To determine the 
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effect of trypanosome infection on the afferent arm of 
the reaction, oxazolone was administered to mice at various 
intervals after infection and the animals were subsequently 
skin tested for delayed hypersensitivity. To determine 
the effect of infection on the efferent arm of the re­
sponse, the animals were first sensitized with oxazolone, 
and after sensitivity was attained the mice were infected 
with 1 dose of T. cruzi. The infected animals and 
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an uninfected control group were then skin tested as before 
at various intervals. The results were expressed as the 
percentage of the second reaction as compared to the first. 
Tests for Humoral Responses in Normal Mice 
and Mice Infected with T. cruzi 
Two antigens, sheep red blood cells (SRBC) and 
alkaline-detoxified bacterial lipopolysaccharide (dLPS) , 
were used to test the humoral response in normal and 
infected mice. 
SRBC (Sheep Red Blood Cells) 
Whole sheep blood was obtained from the Rocky 
Mountain Laboratory, Hamilton, Montana. The blood was 
centrifuged at 2000 x g for 5 minutes and the packed 
layer of red cells retained. These were washed three 
times in sterile phosphate-buffered saline (PBS), pH 7.2, 
O 
and adjusted to a concentration of 2 x 10 red cells/ml, 
n 
or 4 X 10/0.2 ml. Groups of 6 mice each were given iv 
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injections of 0.2 ml of a freshly-prepared suspension of 
SRBC at various days after infection with 1 LD50 dose of 
T. cruzi blood forms. The animals were exsanguinated 
4 days later and their sera pooled. Groups of mice were 
bled on days 6,8, 10, 14 and 16 post infection. 
An uninfected, unsensitized control group was handled 
similarly. The sera was frozen and inactivated at 56 C 
for 30 minutes prior to testing. The sera was tested 
for antibodies by passive hemagglutination, using a 1% 
solution of normal SRBC for the antigen. 
dLPS (detoxified lipopolysaccharide) 
The dLPS was obtained from Dr. Jon A. Rudbach, 
Department of Microbiology, University of Montana, Missoula, 
Montana. Ten pg of dLPS, suspended in sterile PBS, 
pH 7.0, was administered in 0.2 ml volumes. The same 
experimental procedure was used as in the assays for 
antibodies against SRBC. For the antigen in the passive 
hemagglutination assay, SRBC with adsorbed dLPS were used. 
Effects of Infection with T. cruzi on the 
Development of Lymphoblasts in Local 
Lymph Nodes Following Exposure to Oxazolone 
At various days after infection with 1 LD50 dose of 
T. cruzi, groups of 4 mice each received 3 drops (from 
a 25 ga needle) of 3% oxazolone in absolute ethanol on 
the inner surface of each ear. The solution was rubbed 
29 
into the skin with a cotton applicator stick. Four 
days later the auricular lymph nodes were removed from 
each side of the animal's neck. Nodes were removed 10, 
12, 14 and 16 days post infection, as well as from an 
uninfected control group which had received thé same 
oxazolone treatment. Immediately after excision, the nodes 
were put in Plutznik's fixative and stored until all nodes 
for the experiment were obtained. The minimum time in 
the fixative was 24 h. The nodes were then embedded in 
paraffin and sectioned with a Spencer Model F20 microtome 
(7 microns). The sections were mounted and stained with 
methyl-green pyronin, a RNA stain. The slides were 
examined microscopically and the percentage of pyronino-
philic (RNA-rich) cells, termed lymphoblasts, was determined. 
The lymphoblasts in the nodes from sensitized, infected 
mice were compared to those in the nodes of sensitized, 
uninfected mice. As a control, nodes from normal mice 
were observed as well as nodes from infected unsensi-
tized mice. 
Transfer of Contact Sensitivity 
In this and the other cell-transfer studies, C57B1/10 
adult male mice were used. Groups of 6 mice each were 
sensitized with oxazolone on the abdominal region as 
described previously. Seven days later, they were 
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killed by cervical dislocation. Their spleens were 
removed and forced through a fine wire mesh into petri 
plates containing tissue culture media. To avoid formation 
of clots by spleen cells, no more than 2 or 3 spleens 
were combined in the same petri dish, in approximately 
20 ml of media. The number of spleens combined was 
largely a function of spleen size. Animals infected for 
12 or more days with virulent T. cruzi generally have 
greatly enlarged spleens. The cells were allowed to 
settle in a 40 ml centrifuge tube to remove large particles. 
The cell suspension was poured off, and centrifuged at 
250 X g for 5 minutes, resuspended in media, and washed 
2 times. The cells were counted using Turk's solution to 
lyse red blood cells and were adjusted to a concentra­
tion of 2.5 X 10^ white blood cells/ml. Recipient mice 
were injected ip with 0.02 ml of this suspension (a total 
of 5 X 10^ cells/recipient). Twenty-four h after receiving 
cells, the recipient animals were skin tested with oxa-
zolone by applying 1.5%oxazolone in ETOH:olive oil to 
1 ear and diluent only to the other ear. This procedure 
was followed in infected sensitized and uninfected 
sensitized donor mice. Infected sensitized donors were 
used at 8, 10, 14, 16 and 17 days post infection. To 
assay for oxazolone response in the donors, they were 
skin tested 24 h before being killed. The oxazolone 
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response was compared in groups of recipient mice, 
5 mice/group, receiving cells from different groups 
of donors. 
Transfer of contact sensitivity with separate lymphocyte 
populations 
Mice were sensitized with oxazolone as described 
earlier, and their spleens removed 7 days later.. The 
spleen cells were separated by forcing the spleen through 
a wire mesh as before. The cells were then separated 
into populations of B and T lymphocytes as described by 
Hoades , (40), using a nylon wool column. 
Twelve spleens were removed and divided into tubes 
containing 4 0 ml MEM with 2 spleens per tube. The 
erythrocytes were lysed in ammonium chloride and the 
remaining cells were washed 3 times with MEM. One and 
seven-tenths g of nylon wool (FT-242, Fenwal Laboratories, 
Morton Grove, 111) which had been prewashed in glass-
distilled water was packed into the barrel of a 30 ml 
disposable syringe to the 18 ml mark and autoclaved. 
Before cell application, the nylon in the column was 
saturated and rinsed with MEM containing 10% fetal calf 
serum (MEM-FCS), and the column was incubated for 1 h at 
37 C. After this preincubation, 1.6 x 10^ cells, in 15 ml 
warmed MEM-FCS were added to the column, and the prepara­
tion incubated at 37 C in a humidified air-5% CO2 incubator. 
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After the incubation the non-adherent cells were removed 
by adding warmed MEM-FCS to the column, the first 30 ml 
of effluent, the T-cell enriched fraction, was collected. 
The column was washed with 100 ml warmed MEM-FCS and this 
wash was discarded. Adherent cells were removed by com­
pressing the nylon wool with the syringe plunger, removing 
the plunger and teasing up the wool with sterile forceps. 
The wool was resaturated with MEM-FCS and compressed again. 
The process was repeated until about 50 ml containing 
the B-cell enriched fraction were collected. 
Cell surface immunoglobulin as a B-cell marker was 
identified by fluorescein-conjugated rabbit antimouse 
immunoglobulin. Fluorescent cells were identified as 
B-cells and non-fluorescent cells as T-cells. 
Transfer of normal mouse peritoneal exudate cells prior to 
skin testing mice sensitized with oxazolone and infected 
with T. cruzi 
Mice were sensitized with 3% oxazolone 8 days after 
infection with 1 LD__ dose of virulent T. cruzi. Seven 
50 — 
days following sensitization (15 days after infection) 
the mice received 2 x 10^ peritoneal exudate cells from 
normal donor mice and were skin tested immediately. An 
infected, sensitized control group received no cells, and 
a group of normal, unsensitized mice received the same 
dose of peritoneal exudate cells prepared as follows: 
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Normal mice were killed by cervical dislocation. A length­
wise incision was made with a sharp scissors from the groin 
to the chest, taking caution to avoid puncture of the peri­
toneal membrane. Five ml of cold tissue culture media was 
injected with a 26 ga needle into the peritoneal cavity. 
The distended abdomen was massaged for about 30 seconds 
and the media was then withdrawn with a 20 ga needle, 
taking care to keep blood from the exudate suspension. 
The exudate suspension was put in cold siliconized glass 
centrifuge tubes and centrifuged at 250 x g for 5 minutes. 
The white blood cells were counted and resuspended in 
O 
MEM to a concentration of 1 x 10 cells/ml. 
Attempts to transfer sensitivity to oxazolone to normal 
and infected mice 
Spleen cells were harvested as before from groups 
of 7 mice/group which had been previously sensitized 
and skin tested with oxazolone. The cells were washed, 
placed in a plastic petri dish and incubated for 30 
minutes. The non-adherent cells were removed by spray­
ing the dish with media from a syringe and were again 
incubated on a plastic surface. The non-adherent 
cells were removed and adjusted to a concentration of 
2 X 10^ cells/ml and 0.02 ml of this suspension was in­
jected into mice ip. The recipient animals consisted of 
normal mice and of mice that had been infected with 
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1 LDgg dose of virulent T. cruzi 15 days previously. 
Twenty-four h after receiving the spleen cells, the 
animals were skin tested with oxazolone, and the results 
were read after another 24 h. As a control, normal spleen 
cells, handled in the same manner, were injected into 
other groups of normal and infected animals. There were 
5 recipient mice/group. 
Effects of LPS on Mice Infected with T. cruzi 
On various days following ip challenge with 1 LDgg 
dose of virulent T. cruzi, different groups of Swiss 
mice were injected iv with 1.0, 0.5, or 0.1 pg LPS 
(J. A. Rudbach, University of Montana). Mice were given 
LPS on days 9, 12, 14, 16 and 18 days after infection. 
Deaths within 12 h after LPS injection were quantified 
and used for comparative data. 
Statistics 
The Mann-Whitney test was used to analyze the data. 
Chapter 3 
RESULTS 
Determination of the LP of the 
Tulahuen Strain of T. cruzi in RML Mice 
Mice consistantly died about 18 days following 
infection with 1 x 10^ blood forms of T. cruzi. The 
average time of death was less predictable when lower doses 
were used, so 1 x 10 parasites were chosen as the challeng­
ing dose. This provided the longest working period after 
infection within a predictable course of infection. 
Challenge with only 10-20 parasites would often kill mice 
by 30 days or more, but survivors were often noted when 
low challenge doses were used. Route of infection was 
found to make little difference; iv and sc challenge pro­
duced similar results. C57B1 mice were found to approximate 
the Swiss mice in their susceptibility. In all cases, 
males were more susceptible than females, and young animals 
were more susceptible than older ones (Fig. 1). 
Immunization Studies 
Effects of immunization with BCG and/or live attenuated 
T. cruzi on the course of infection in mice challenged 
with virulent T. cruzi 
Mice were protected against lethal challenge with 
blood forms of T. cruzi by ip inoculation of one dose of 
attenuated T. cruzi given 18 days prior to challenge or by 
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Fig. 1. Determination of the LDg^ in RI4L mice. Mice 
were six weeks old, and injected ip. 
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two doses of the same preparation give 18 and 7 days prior 
to challenge (Table 1). A single inoculation of the 
attenuated organisms given 7 days before challenge did 
not give good protection. Immunization with BCG gave 
little or no protection, although some protection was noted 
in mice receiving BCG 40 and 18 days before challenge. 
A loss of effectiveness of protection due to specific 
immunization was noted in mice immunized with both attenuated 
T. cruzi and BCG. Good protection was apparent in mice 
receiving 1 or 2 doses of attenuated trypanosomes (groups 
6 and 8) but animals were not completely protected by the 
same treatment if they had been previously immunized with 
BCG (groups 2,3,4,5,7). This was true in all cases except 
that in which mice were treated with 2 doses of BCG and 2 
doses of attenuated trypanosomes. 
Effects of BCG immunization iv on the course of infection 
with T. cruzi 
Mice immunized iv with BCG 1 and 11 days prior to 
challenge with 50 doses of T. cruzi survived signifi­
cantly longer than did normal mice, although 7 of 8 were 
dead by the 19th day of infection (Table 2). Mice 
challenged with 2 LD^Q doses showed a similar trend, 
although the differences were not significant. Very little 
difference in survival time was seen between groups 
receiving 1 or 2 doses of BCG. 
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Table 1. Effects of Immunization with BCG and Attenuated 
Trypanosoma cruzi Trypomastigotes on the Survival Time of 
Mice Infected with Virulent T. cruzi.a 
Number Survival Times 
^ ̂  . Dead/Total (days) 
BCG® BCG ATC ATC x Range 
Group Immunizations 
d-40b d-lgc d-7^ 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0/8 
2/8 
2/8 
4/8 
3/8 
0/8 
4/8 
0/8 
6/8 
8/8 
5/8 
8/8 
16.0 
28.5 
20.5 
26.3 
2 0 . 0  
2 8 . 0  
17.9 
2 0 . 2  
17.8 
15-17 
17-30 
17-26 
17-38 
17-26 
17-32 
16-30 
19-25 
16-20 
a challenged with 5 x 10 virulent blood forms 
(5 LD^Q doses) ip 
^ 40 days prior to challenge 
^ 18 days prior to challenge 
^ 7 days prior to challenge 
® Paris strain; approx. 1 x 10^ viable organisms/dose 
f attenuated live T. cruzi culture forms; approx. 
1 x 10°/dose ip 
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Table 2. Effects of iv Immunization with BCG on the 
Survival Time of Mice Challenged with Virulent 
Trypanosoma cruzi. 
Group BCG Number No. Dead/ Survival Times 
Immunizations^ Challenge Total (days) 
d-lic d-11, d-lG 
1 + 
2 -
3 - + 
4 
5 + 
^ Paris strain of BCG; approx. 
1 X 10 viable organisms/dose 
^ No. LD50 doses of virulent blood forms, ip 
^ 1 injection of BCG 11 days before challenge 
^ 2 injections of BCG 11 and 1 days before challenge 
doses" X Range 
50 7/8 16.2 13-19 
50 8/8 13.4 13-15 
2 8/8 20.3 17-30 
2 8/8 17.2 16-20 
2 8/8 20.3 17-27 
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Effects of immunization with live and killed culture forms 
on the course of infection with virulent T. cruzi 
All mice given 2 x 10^ live attenuated T. cruzi 20 
days prior to challenge survived infection, regardless of 
the route of immunization (Table 3). Killed culture forms 
offered little protection with any of the immunizing methods. 
employed. 
Effect of Treatment with Silicon Dioxide Particles on the 
Course of Infection with T. cruzi 
Mice receiving 2 doses of silica, at any of the 
concentrations used, died significantly faster when infected 
with T. cruzi than did infected control mice (Table 4). The 
mice treated with a single dose of 10 or 4 0 mg of silica 
also differed significantly from the controls in their 
survival times. The group treated with one 20 mg dose did 
not differ significantly from controls in survival time. 
There were 4 survivors in this group, as compared to 2 in 
the group given one 40 mg dose of silica, and 1 in the 
control group. 
Course of Infection with T. cruzi 
Reticuloendothelial clearance of colloidal carbon particles 
in mice infected with T. cruzi 
Mice infected with T. cruzi (16 days after receiving 
1 LD dose) were able to remove colloidal carbon from 
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their bloodstream significantly faster than normal animals 
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Table 3. Effects of Immunization with Live or Killed 
Attenuated Trypanosoma cruzi on the Survival Time of Mice 
Challenged with Virulent Trypanosoma cruzi. 
Group Immunization^ Days Before No. Dead/ Survival Times 
Challenge^ Total (days) 
% Range 
1 L, iv^ 20 0/8 — —  
2 L, ip^ 20 0/8 — — 
3 K, ivG 20 5/8 21.0 18-26 
4 K, ip 20 4/8 20.5 19-22 
5 —  —  8/8 18.3 17-19 
^ approx. 2 x 10^ attenuated T. cruzi, live or killed 
per dose 
^ approx. 2 x 10^ virulent blood forms (2 LD^Q doses), 
ip injection 
^ live T. cruzi, iv injection 
^ live T. cruzi, ip injection 
0 
T. cruzi killed by freeze-thaw method 
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Table 4. Effects of Treatment with Silica on the Survival 
Time of Mice Infected with Virulent Trypanosoma cruzi.^ 
Group Dose Silica Treatment^ No. Dead/ Survival p 
d-1 d 0 d-l,d 0 Total Times 
% 
(days) 
Range 
<0.05 
1 lOmg + — — 8/8 18.0 15-20 + 
2 I I  - + 8/8 18.3 17-20 + 
3 I I  - + 8/8 17.8 16-20 + • 
4 20mg + — — 5/8 18.6 16-26 -
5 I I  - + 7/8 20.7 18-26 -
6 I I  - + 8/8 17.8 16-20 + 
7 40mg 4- — — 7/8 17.4 16-19 + 
8 I I  - + 7/8 17.4 16-19 + 
9 I I  - — + 8/8 17.5 16-19 
10 none - — — 7/8 19.7 16-21 
^ all mice challenged ip with 1 x 10^ T. cruzi blood 
forms 
^ silica particles given ip the day before challenge 
(d-1), the day of challenge (d 0), or on both days 
(d-1, d 0) 
^ p value for Mann-Whitney significance test; level 
of significance when compared to control group (10) 
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(Fig. 2, Table 5). Control readings of blood from normal 
and infected mice were approximately the same, indicating 
that the presence of trypanosomes in the blood samples did 
not alter the results. 
Changes in spleen weights during the course of infection 
with T. cruzi 
Individual spleen weights increased dramatically as 
the infection progressed (Fig. 3, Table 6). This increase 
in the weights of individual spleens was apparent 8 days 
after infection was induced. 
Changes in total blood cell count during the course of 
infection with T. cruzi 
Total erythrocyte and leukocyte counts were lower in 
acutely infected mice than in normal mice. Erythrocyte 
numbers delined from 11-12 x lO^/ml to about 6 x 10^/ml 
as the infection approached the terminal stage. Leukopenia 
was also noted; the total white cell counts decreased from 
2-3 X 10^/ml to 0.9-1.4 x 10^/ml. There was no apparent 
selective decline of a single leukocyte population (Fig. 4&5). 
Course of parasitemia during infection with T. cruzi 
(Fig. 6, Table 7) 
The number of circulating trypanosomes rose logrith-
mically following ip injection of 1 dose of T. cruzi. 
Eighteen days after infection, parasite levels ranged from 
6-20 X 10^/ml blood. 
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Table 5. Reticuloendothelial Clearance of Colloidal 
Carbon in Mice Infected with Trypanosoma cruzi. 
Time (minutes) % Transmittance^ p ̂ 0.05^ 
Injection Normal Infected^ 
'2 16.2 30.2 + 
6 17.8 30.6 + 
10 20.2 29.8 + 
20 21.2 32.4 + 
^ infected with 1 x 10^ virulent blood forms 
T. cruzi ip 16 days prior to carbon injection 
^ average value for 5 mice; % transmittance 
spectrophotometrically 
^ p value for Mann-Whitney significance test, 
comparing normal group to infected group 
Fig. 2. Reticuloendothelial clearance of colloidal 
carbon in mice infected with T. cruzi. Mice were tested 
16 days after infection with 1 x 10 blood forms. Clear­
ance was determined by evaluating blood withdrawn at 
intervals for spectrophotometric transmittance. 
Symbols: infected mice— 
normal mice. 
% TRANSMITTANCE (AVERAGE READING FOR GROUP 
OF 5  MICE) 
Table 6. Changes in Spleen Weight During the Course 
of Infection with Trypanosoma cruzi. 
No. Days Ave. Spleen Wt. (g)^ 
Infected^ 
0.12 
2 0.12 
4 0.13 
6 0.17 
8 0.28 
10 0.54 
12 0.55 
14 0.68 
16 0.68 
18 0.74 
^ infection with 1 LD dose of 
T. cruzi blood forms ip 
^ average value of 5 mice 
Fig. 3. Changes in spleen weights during the course 
of infection. Mice were infected ip with 1 x 10^ blood 
forms. 
AVERAGE WEIGHT (GRAMS) 
Fig. 4. Changes in blood cell numbers in mice infected 
with T. cruzi. Mice were infected ip with 1 x 10 
blood forms. Cell counts for groups of 5 mice each were 
averaged. N represents the average value for uninfected 
male RML mice, 6 weeks of age. 
Symbols: leukocyte counts 
erythrocyte counts — 
NUMBER OF LEUKOCYTES X 10 
NUMBER OF ERYTHRECYTES X 10 
Fig. 5. Differential leukocyte counts during the course 
of infection with T. cruzi in RML mice. Mice were in-
3 fected ip with 1 x 10 blood forms. N represents the 
average value for uninfected mice. 
Symbols; neutrophils 
lymphocytes 
monocytes 
eosinophils —— 
% OF TOTAL LEUKOCYTE NUMBER 
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Table 7. Course of Parasitemia During 
Infection with Trypanosoma cruzi. 
No. Days No. Trypanosomes/ 
Infected^ ml Blood 
8 6 X 10^ 
10 2 X 10^ 
12 6 X 10^ 
14 5 X 105 
16 3 X 10® 
18 4 X 10® 
^ infected with 1 x 10^ virulent 
blood forms of T. cruzi ip 
Fig. 6. Course of parasitemia during infection with 
T. cruzi. Mice were infected ip with 1 x 10^ blood 
forms. 
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Effect of infection with T. cruzi on the inflammatory 
response 
Significant differences in ear thickness were seen 
between infected and control mice 24 h after injection of 
a turpentine : olive oil mixture. The mice treated with 
cortisone developed a lowered inflammatory response. It 
was less than those of the other 2 groups of animals tested; 
and cortisone-treated mice showed a more rapid regression 
of inflammation than did normal animals (Table 8). 
Tests for Delayed Hypersensitivity (DH) in 
Normal Mice and Mice Infected with T. cruzi 
CFA 
Groups of 8 mice each were infected with T. cruzi 
either 4 days before, on the same day, 4 days after or 
9 days after sensitization. The animals were subsequently 
tested for delayed hypersensitivity 14 days after sensiti­
zation. Thus the mice were tested 5, 10, 14 or 18 days 
after infection with T. cruzi. As shown in Fig. 7, mice 
tested on days 5 and 10 after infection had delayed 
hypersensitivity reactions roughly equivalent to those of 
uninfected mice. Those tested 14 or 18 days after infection 
had markedly decreased delayed responses. These 2 groups 
differed significantly from the uninfected mice. 
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Table 8. Effects of Infection with Trypanosoma 
cruzi on the Inflammatory Response in Mice. 
a d Group Treatment Inflammatory Response (mm) p <^0.05 
1 none 0.42 -
2 T. cruzi^ 0.32 + 
3 cortisone^ 0.25 + 
^ 0.05 ml of a 1: 5 mixture of turpentine :olive oil was 
injected in one ear; 0.05 ml saline was injected into 
the other. Difference between thickness of the 2 ears 
was recorded 24 h later. 
^ 1 X 10^ blood forms injected ip 16 days prior to test 
^ hydrocortisone acetate, 50 mg/kg, given ip 24h prior 
to test 
^ Mann-Whitney significance test used to analyze the 
data compared to normal control (group 1) 
Fig. 7. Suppression of delayed hypersensitivity to 
12.5 vg BCG protoplasm injected into the footpad of 
mice immunized with BCG and infected with T. cruzi. 
Each point represents the mean response of 8 mice, skin 
tested 14 days after sensitization with CFA. 
Symbols : infected mice 
normal mice 
MEAN FOOTPAD THICKNESS (MM) 
62 
Oxazolone 
Influence of infection with T. cruzi on the induction of 
delayed hypersensitivity. In the experiment shown in 
Fig. 8, groups of mice were sensitized with oxazolone on 
days 0, 4, 8 and 10 after infection with T. cruzi and tested 
for sensitivity to oxazolone 8 days after sensitization 
(8, 12, 16 and 18 days after infection). Mice sensitized 
with oxazolone on the day of infection displayed delayed 
hypersensitivity to oxazolone when tested 8 days later, 
whereas animals given oxazolone on the fourth day after 
infection and tested 12 days after infection showed a 
marked decrease in the response. The response to oxazolone 
was further decreased in mice sensitized 8 and 10 days 
after infection and tested 16 and 18 days after infection, 
respectively. The 3 latter groups of infected animals 
differed significantly in their response from the uninfected 
controls. 
Influence of infection with T. cruzi on the expression of 
delayed hypersensitivity. A rise in response to oxazolone 
was noted in uninfected mice as the time following the 
first skin test increased (Fig. 9). However, infected 
mice that had been sensitive to oxazolone before infection 
became less responsive as the infection progressed. This 
loss of sensitivity was first apparent by the fourteenth day 
Fig. 8. Suppression of delayed hypersensitivity to 
oxazolone applied to the ears of mice sensitized with 
oxazolone and infected with T. cruzi. Each point repre­
sents the mean response at 8 days after sensitization 
with oxazolone. 
Symbols infected mice 
normal mice 
MEAN EAR THICKNESS (MM) 
Fig. 9. Decreased ability of mice infected with T. cruzi 
to express delayed hypersensitivity to oxazolone. Each 
point represents the mean response of 8 mice. All mice 
were sensitive to oxazolone prior to infection. 
Symbols; infected mice 
normal mice 
MEAN EAR THICKNESS (% OF INITIAL RESPONSE) 
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after infection. Again, the 3 groups of mice infected 
the longest (14, 16 and 18 days) differed significantly 
in their responses from the uninfected mice. 
Effects of immunization with attenuated T. cruzi on delayed 
hypersensitivity to oxazolone. Mice immunized with 2 
doses of live attenuated T. cruzi 14 and 7 days prior to 
challenge with virulent trypanosomes developed greater 
sensitivity than did unimmunized animals (Fig. 10). Both 
groups of mice were infected 8 days prior to sensitization 
with oxazolone and tested for DH 16 days after infection. 
Mice immunized with the attenuated trypanosomes showed 
consistently higher levels of sensitivity to oxazolone 
than did normal mice. This state of increased responsive­
ness occurred in both challenged and unchallenged mice. 
The responses differed significantly only between the 
sensitized, infected animals and the other groups. 
The cellular response in auricular lymph nodes of normal 
and infected mice sensitized with oxazolone. The medullary 
areas of the auricular lymph nodes from normal mice 
sensitized 3-4 days earlier by applying oxazolone to the 
ear showed a large number of lymphoblasts. These are large, 
pyroninophilic cells easily distinguished from unstimulated 
cells. Auricular nodes taken from unsensitized mice that 
had been infected with T. cruzi, 1 LD^Q dose for 16 days. 
Fig. 10. Effects of immunization with attenuated T. cruzi 
on delayed hypersensitivity to oxazolone in mice infected 
with T. cruzi. Each bar represents the mean response 
of 8 mice. 
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also had high numbers of large, pyroninophilic cells. 
However, in these animals, the occurance of these cells 
was noted in both the medullary and cortical areas. The 
nodes from infected animals are also enlarged, as are those 
from normal sensitized animals, due to the generalized 
adenopathy resulting from infection. 
The nodes from infected, sensitized mice had a propor­
tionally higher content of lymphoblasts than those from 
infected, unsensitized mice. These differences were 
apparent in the medulla, but the cortical areas showed 
little difference in the number of lymphoblasts (p. 71). 
Transfer of Contact Sensitivity 
Delayed hypersensitivity to oxazolone is readily 
transferrable between inbred mice (Table 9). Spleen 
cells were used in these studies, although better results 
may be often obtained using peritoneal exudate cells. 
Fewer cells are required if peritoneal exudate cells are 
used, and a 24 h delay from the time of transfer to the 
time of skin test is not necessary. 
Lymphocyte populations were separated from spleens 
removed from mice sensitized 7 days earlier with oxazolone. 
The lymphocytes were divided into B-cell enriched and T-cell 
enriched populations by passage through a nylon wool column. 
Groups of syngeneic recipient mice received equal numbers 
of cells from either the T-cell or B-cell fraction or a 
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Table 9. Spleen Cell Transfer of Contact Sensitivity 
from Infected to Uninfected C57B1/10 Mice. 
Number of Days Donor Recipient p^ 
Donors^ Infected Response (mm)b Response (mm)^ 
X ± SD X ± SD 
0 0.60 ± 0.10 0.50 ± 0.07 >0.05 
10 0.55 ± 0.10 0.45 ± 0.10 >0.05 
14 0.28 ± 0.09 0.42 ± 0.11 £0.01 
16 0.05 ± 0.05 0.40 ± 0.09 <0.01 
17 0.05 ± 0.05 0.44 ± 0.12 <0.01 
^ sensitized with oxazolone 7 days before cell 
transfer 
^ oxazolone skin test immediately before transfer 
^ oxazolone applied at 24 h and skin tested at 48 h 
after receiving 3 x lO^ spleen cells from infected, 
sensitized donors 
^ p value from Mann-Whitney significance test; 
donor vs. recipient 
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comparable number of a 50-50 mixture of the 2 fractions. 
The T-cell fraction was significantly more effective in 
transferring contact sensitivity than was the B-cell 
fraction. The mixture was intermediate in effectiveness. 
Spleen cells from infected, sensitized donors were 
able to confer specific sensitivity upon normal recipients, 
regardless of the stage of infection of the donors. Sensi­
tized mice that were unable to respond to eliciting doses 
of oxazolone possessed spleen cells capable of conferring 
sensitivity to oxazolone as effectively as cells of unin­
fected animals. No significant differences were seen in 
the responses of the recipient animals when donor cells 
from normal mice or mice at different stages of infection 
were used. (Table 10) 
Transfer of normal mouse peritoneal exudate cells to mice 
sensitized with oxazolone and infected with T. cruzi 
Mice infected 15 days previously with 1 LD^Q dose of 
T. cruzi and sensitized to oxazolone on the eighth day 
following infection were given peritoneal exudate cells 
iv from normal mice immediately before skin testing on the 
fifteenth day. These mice were able to respond to oxazo­
lone significantly better than infected, sensitized mice 
which did not receive peritoneal cells (Table 11). 
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Table 10. Transfer of Contact Sensitivity in C57B1/10 
Mice with Separated Spleen Cell Populations. 
Statistical Analysis 
Groups Compared p ̂ 0.05® 
B vs. B + T + 
T vs. B + T + 
T vs. B + 
^ 5 recipients/group, 1.25 x 10 cells/recipient; 
skin tested with oxazolone (1.5%) 24 h after 
cell transfer, read 48 h after cell transfer 
^ B-cell enriched; shown to be approx. 95% B-cells 
by immunofluorescence 
^ 50% B-cell fraction and 50% T-cell fraction 
T-cell enriched; shown to be approx. 80% T-cells 
by immunofluorescence 
® Mann-Whitney significance test applied 
Population of Response (mm) 
Cells Received of Recipients 
% ± SD 
b'̂  0.21 ± 0.06 
B + T^ 0.38 ± 0.12 
T^ 0.46 ± 0.12 
none 0.10 ± 0.02 
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Table 11. Restoration of Skin Test Response to Oxazolone 
by Transfer of Normal Peritoneal Exudate Cells to Mice 
Sensitized with Oxazolone and Infected with T. cruzi. 
Treatment Response (mm) p^ 
X ± SD 
Peritoneal Exudate Cells^ 0.28 ± 0.08 £0.01 
None 0.04 ± 0.05 
^ 2 X 10^ cells given iv at time of application of 
skin test dose of oxazolone 
^ the Mann-Whitney test was used to analyze the data 
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Transfer of spleen cells from mice sensitized with 
oxazolone to normal mice and infected mice 
Mice infected for 16 days with 1 LD_. dose of T. cruzi 
50 — 
responded significantly less to eliciting doses of oxazo­
lone than did normal mice following transfer of spleen 
cells from uninfected sensitized donors (Table 12). 
Lymph node cell transfer of contact sensitivity from 
infected to uninfected mice 
Auricular lymph nodes from normal and infected mice 
which had been sensitized by application of oxazolone to 
both ears 3 days before, were removed and transferred to 
normal recipients. This experiment was done to ensure 
that sensitization was carried out during the stages of 
high parasitemia and greatest immunosuppression. Both 
infected and uninfected mice transferred contact sensitivity 
to normal recipients. No significant difference was ob­
served between the two groups of recipients (Table 13). 
Effects of LPS iv on Mice Infected with T. cruzi 
Normal Swiss mice inoculated iv with 1.0, 0.5 or 
0.1 pg of LPS displayed no visable effects (Table 14). 
However, many of the infected mice inoculated with the 
same amount of LPS died shortly after administration of 
this material. Deaths due to inoculation with LPS were 
first noted 9 days after the mice were infected with 1 
LD_„ dose of T. cruzi, and became more frequent as the 
50 — 
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Table 12. Spleen Cell Transfer of Contact Sensitivity 
to Infected and Uninfected C57B1/10 Mice. 
Skin test Response (mm) p*^ 
JT ± SD 
Donors^ 0.60 ± 0.10 
Recipients''^ 
infected 0.22 ± 0.05 <0.01 
Recipients' 
uninfected 0.47 ± 0.06 <0.01 
Infected Control 0.05 ± 0.05 <0.01 
^ uninfected mice sensitized with oxazolone 7 days before 
' oxazolone applied 24 h and skin tested 48 h after 
receiving 3 x 10^ spleen cells from sensitized 
donors 
peak parasitemia stage, 16 days following 
ip injection of 1 LD^g dose 
^ data analyzed with Mann-Whitney significance 
test; comparisons made to donor values. The 
recipient groups also differed significantly from 
each other at the 0.01 level. 
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Table 13. Lymph Node Cell Transfer of Contact Sensitivity 
from Infected to Uninfected C57B1/10 Mice. 
No. of Days Donors^ Recipient Response p^ 
Infected x ± SD 
0 0.30 ± 0.08 
16^ 0.26 ± 0.10 
>0.05 
oxazolone (2%) applied to both ears three days 
prior to removal of auricular lymph nodes and 
cell transfer (5 mice/group) 
^ p value from Mann-Whitney significance test 
comparing recipient groups 
C 1 
infected with 1 x 10 blood forms ip 16 days 
before cell transfer of 5 x 10® lymphocytes 
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Table 14. Increased Susceptibility to Endotoxin 
in Mice Infected with Trypanosoma cruzi. 
Number of Days Infected at Number of Deaths/Total 
Time of Endotoxin Administration Following iv Injection 
of Endotoxin 
0. Ipg 0. Syg 1. Oyg 
6 0/4 0/4 0/4 
9 0/4 2/4 0/4 
12 0/4 2/4 2/4 
14 1/4 2/4 1/4 
16 2/4 4/4 4/4 
18 4/4 4/4 4/4 
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infection progressed. Deaths were usually directly 
proportional to the number of days the animals had been 
infected and the amount of LPS administered. 
Humoral Responses to SRBC and dLPS 
Mice showed a decreased ability to produce antibodies 
against both SRBC and dLPS as the infection progressed 
(Fig. 11). Decreased production of antibodies against dLPS 
was first noted on the fourteenth day after infection, and 
was most marked just before death. On the other hand, 
antibodies against SRBC were not decreased until late in 
the course of infection. 
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Illus. 5. Ear, normal mouse, hematoxylin and eosin (H & E) 
224X. 
Illus. 6. Ear, normal mouse sensitized to oxazolone. 
Mouse sensitized to oxazolone 8 days and skin tested 
1 day prior to removal of ear. Note extensive infiltration 
of monocytic cells. H & E 224X. 
Illus. 7. Ear, infected mouse sensitized to oxazolone. 
Mouse infected ip with 1 x 10^ blood forms 16 days prior to 
removal of ear. Mouse was sensitized andskin tested as 
above. H & E 224X. 
Illus. 8. Ear, infected mouse sensitized to oxazolone, 
with macrophages administered prior to skin test (Table 11). 
H & E 224X. 
Illus. 9. Ear, oxazolone sensitized, monocyte infiltration. 
Typical cells of the sensitized ear. H & E 1400X. 
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Chapter 4 
DISCUSSION 
The results presented in this study demonstrate a 
number of interesting aspects of the immune responses 
occurring in mice with acute Chagas' disease. The informa­
tion can be divided into two main areas: 1) studies on 
resistance to T. cruzi infection in the mouse, and 2) ef­
fects of acute infection on the immune responses of the 
mouse. Since T. cruzi is an intracellular parasite, in­
fections with this organism provide an informative model 
for study of host-parasite interactions on a cellular 
level. In addition, the presence of virulent T. cruzi in 
a susceptible host affects the host's ability to mount an 
immune response to antigens unrelated to those of the para­
site. Thus, studies of T. cruzi infection can be used to 
obtain specific knowledge of the immune system as well as 
specific information on the host-parasite relationship in 
this particular disease. 
Immunization Studies 
Both specific and non-specific immunization proce­
dures were used in attempts to protect mice against vir­
ulent challenge with T. cruzi. Mice were immunized with 
live attenuated Mycobacterium bovis (BCG), a non-specific 
stimulator of the cellular immune response, or with 
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preparations of either live attenuated or killed at­
tenuated T. cruzi. The parasites are attenuated by re­
peated passage in culture. These organisms are viable 
when introduced, but are not able to produce disease or 
persistent infection in mice. 
Since the Tulahuen strain of T. cruzi is an intra­
cellular parasite preferring cells of the reticuloendo­
thelial system, it appeared likely that BCG, which ac­
tivates phagocytic cells, might be useful for protecting 
mice against the intracellular trypanosomes. However, 
all reports (69) but one have indicated that this is not 
the case. In the present study, as in most others, BCG 
was of little or no value in protecting mice against 
virulent challenge with T. cruzi. This appears to be a 
rather unusual situation, for BCG has been proven suc­
cessful in protecting against a wide variety of intra­
cellular parasites, including many viruses and bacteria, 
as well as Leishmania (86) and Plasmodium (13) infections. 
It is apparent that the route of immunization in­
fluences the effectiveness of BCG as a protecting agent. 
Clark et (13) have reported successful immunization 
with BCG only if administered iv for protection of ex­
perimental animals against malaria. Similarly, Ortiz-
Ortiz (19) reported successful immunization utilizing iv 
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administration of BCG prior to challenge of mice with 
virulent T. cruzi. In the present study, an attempt to 
repeat this experiment was less successful than that re­
ported by Ortiz-Ortiz et. a]^. This may be due to differ­
ences in virulence of the strain used. However, in the 
present study, mice receiving iv treatment with BCG did 
survive significantly longer than unimmunized controls, 
although all but one of the immunized mice died from the 
parasitic infection. Kuhn et al. (54) have reported 
complete lack of protection against challenge with the 
virulent Brazilian strain in mice pretreated with high 
doses (3 mg wet weight) of BCG iv. In Kuhn's experiments, 
similar numbers of trypanosomes were used for challenge 
as in the experiments reported here. 
In contrast to the slight degree of protection seen 
in mice immunized with BCG iv, none was seen in mice 
which received BCG ip. This is in agreement with the 
results reported by Hoff (42) who found that macrophages 
from mice injected ip with BCG were able to destroy the 
trypanosomes ̂  vitro, but that protection was not seen. 
Hoff suggests that, although BCG may non-specifically 
activate macrophages to increase their phagocytic and 
cytolytic capabilities, specific stimulation may be 
required vivo to produce a population of lympho­
cytes directed against the parasites. 
89 
Mackaness (58) has shown that specific immunological 
mechanisms may activate macrophages, but once they are 
activated they show an increased ability to engulf and 
kill organisms unrelated antigenically to the original 
immunogen. Organisms such as BCG, Corynebacterium parvum, 
or Listeria monocytogenes are known to non-specifically 
activate macrophages (2, 35, 87). Animals stimulated 
immunologically by these agents are more resistant to 
infection with many bacteria, viruses, and tumors. Treat­
ment of mice with C. parvum has been shown to be effective 
in protecting them against malaria infections, even when 
the immunizing organisms were first killed (68). 
The only proven method of obtaining consistent pro­
tection against T. cruzi is by injection of specific 
T. cruzi antigen, preferably in the form of live avirulent 
organisms. In addition to attenuated culture forms 
shown to be effective in this study, avirulent strains 
obtained from non-human hosts may be used (42). Parasites 
treated with irradiation and, more recently, those killed 
with sodium perchlorate have been shown to be of protec­
tive value (48, 49). It should be remembered that studies 
of this type may not always be reliable due to the 
tremendous variation in the virulence of parasites in any 
given host species. 
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In this study, it was repeatedly demonstrated that 
treatment of mice with one or two doses of attenuated 
culture forms rendered mice resistant to challenge with 
one dose of virulent trypanosomes, provided that 
the antigen was given sufficiently ahead of challenge 
(Table 1). Mice given this treatment 18 days prior to 
challenge were completely protected, but were not if given 
the antigen only seven days before challenge. It is 
suggested that cell-mediated immunity is involved in this 
protection. Culture forms killed by freeze-thawing failed 
to confer protection (Table 3). With the single exception 
noted above, nearly all attempts to immunize mice with 
killed trypanosomes have been unsuccessful. In general, 
cell-mediated immunity is best produced by administering 
a preparation of live, attenuated organisms as opposed to 
killed preparations. Even though the attenuated trypano­
somes do not persist after introduction into mice, they 
cause a slight and transient parasitemia, and provide a 
more prolonged antigenic stimulation. A similar effect 
may be achieved by the use of certain adjuvants combined 
with specific trypanosome antigen (44), but killed prep­
arations alone are generally ineffective. 
An interesting aspect of the immunization experi­
ments was the observation that mice treated with BCG 
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prior to the administration of live culture forms were not 
completely protected against virulent challenge. In con­
trast to this, mice which were not first treated with BCG 
were always protected after immunization with live culture 
forms. This phenomenon has since been verified by 
Kiersenbaum (48) who found that mice pre-treated with 
C. parvum were not completely protected by a preparation 
of T. cruzi antigen proven effective in normal mice. It 
may be that non-specific activation of macrophages is 
not a useful procedure for increasing vivo killing of 
T. cruzi, and, in fact, may even be deleterious. As 
pointed out previously, Hoff (42) has found non-specifi-
cally activated macrophages to be more effective ̂  vitro 
in destroying T. cruzi. However, in our laboratory we 
have seen consistently that mice immunized with BCG are 
not protected against challenge with T. cruzi, and often 
die more rapidly. It might be postulated that, in_ vivo, 
macrophages are capable of taking up the parasite, but 
cannot destroy it. Since the organism is an intracellular 
one, activated macrophages may simply be more accommodat­
ing in providing an environment in which the parasites 
can divide. This argument is not supported by the vitro 
studies, which show that the activated macrophages are 
capable of killing the parasites after ingestion. Perhaps 
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in vivo other factors are important. One possible ex­
planation might be directed toward the T-cell population, 
with the postulation of a group of suppressor T-cells. 
Such cells are seen in animals with tumors or immuno-
depressed aged animals (82) . However, evidence for their 
presence in this instance is quite weak, especially in 
view of all the instances in which BCG provides non­
specific protection. It may be simply that macrophages 
can more easily engulf parasites in an ̂  vitro situation, 
perhaps due to artificially concentrating the phagocytes 
on a plastic surface enabling them to trap and break 
down the parasite more effectively. 
A decrease in the ability of the attenuated trypano-
somes to protect mice immunized previously with BCG may 
be explained on the basis of reticuloendothelial stimula­
tion by the BCG. Perhaps administration of BCG stimu­
lates the macrophages to kill and degrade the immunizing 
trypanosomes. This could prevent production of specific 
cell-mediated immunity by the attenuated trypanosomes 
since they may not persist as long in the BCG-stimulated 
host. 
The effects of treating mice with BCG and attenuated 
trypanosomes can be seen in Table 1. Of the groups of 
mice that received both organisms, only those mice in 
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group one, which had two injections of each preparation, 
survived totally. It appears that in this case, the effect 
of two doses of trypanosomes overcame any adverse effect 
due to the BCG. The only other groups in which all sur­
vived were those that received only attenuated trypano­
somes, either 18 or 18 and 7 days beofre challenge. A 
single immunizing dose of trypanosomes given less than 
12-14 days prior to challenge is not effective in providing 
complete protection.' Groups of mice that received immu­
nizing doses of trypanosomes sufficiently ahead of challenge, 
but which were previously treated with BCG, showed only 
about 50 per cent survival. BCG alone, given ip, did not 
significantly increase numbers of survivors or survival 
time, although two doses were consistently more effective 
than one. When BCG was given iv, somewhat better results 
were obtained as far as increasing survival time. Mice 
given two iv injections of BCG 11 and 1 day prior to 
challenge survived significantly longer than their un-
immunized counterparts (Table 2). This was consistent 
when challenge was with either two or fifty LDgg doses. 
In addition, a single iv injection of BCG given 11 days 
before challenge increased survival time significantly. 
These results indicate that non-specifically activated 
macrophages may be able to confer at least partial 
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protection. Perhaps iv administration of the BCG allows 
for better contact of the organisms with the phagocytic 
cells of the liver, spleen and lungs, the most important 
organs of the reticuloendothelial system. Activation of 
cells in these areas may be useful against the circulat­
ing blood forms, providing increased contact between 
activated host cells and the parasite. It should be 
noted, however, that increased survival time does not 
always indicate protection. The mice treated with BCG 
nearly all died, averaging about eight days longer sur­
vival than the unimmunized groups. 
Not only was a live vaccine preparation found to be 
effective in producing immunity, but, as indicated pre­
viously, a minimum time of 12 to 14 days was necessary 
between immunization and challenge for the preparation to 
be effective. This time period corresponds to that re­
quired for macrophage activation following a primary 
stimulus (70) . In most experiments a single immunizing 
dose protected as effectively as two. 
Further evidence of the importance of the macro­
phage in producing resistance was seen in experiments in 
which silicon dioxide, a macrophage toxin, was used in 
conjunction with infection with T. cruzi. The results 
generally agreed with those obtained by Kiersenbaum et al. 
(47) who found that depression of reticuloendothelial 
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activity by silica resulted in decreased resistance to 
infection with T. cruzi. In addition, these workers 
reported that stimulation of the reticuloendothelial 
system (RES) by diethylstilbesterol before infection 
reduced both mortality rates and levels of parasitemia. 
An interesting situation exists in this system, 
since the Tulahuen strain of T. cruzi multiplies within 
macrophages. It might therefore be expected that selec­
tive killing of macrophages prior to infection could 
actually lead to a lowered parasitemia by decreasing the 
number of available cells in which the parasites can 
divide. Initially we believed this was the case, since 
there were often more survivors in those groups receiving 
the highest doses of silica. However, repeated experi­
mentation with varying doses of silica and times of ad­
ministration proved these instances to be isolated and 
inconsistent in occurrence. Overall, the data indicated 
a significantly longer survival time in the untreated 
mice. 
Some of the inconsistencies observed with macrophage 
activation studies and resistance of animals to T. cruzi 
infection may be due to the preference of many strains 
for cells of the RES. Studies of macrophage activation 
with BCG may be complicated by the involvement of two 
intracellular organisms trying to inhabit the same 
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population of cells. Data using non-living RES activators 
and depressors may be more useful in determining the roles 
of the RES in resistance against T. cruzi infection. 
Kuhn and Durum (5 3) have shown with adoptive transfer 
experiments that the onset of the ability of mice infected 
with T. cruzi to transfer immune protection via lympho­
cytes occurs about nine days after infection. Recipients 
of spleen cells from infected donors were resistant to 
subsequent challenge given three hours after the cells. 
It was noted that high parasitemias did not correlate 
with survival times, since the passively immunized mice 
survived infection but developed high parasite levels. 
This immunity appears to differ from that actively con­
ferred with attenuated trypanosomes as described in these 
experiments, for high parasitemias did not develop 
following challenge of actively immunized mice. 
To explain their observations, Kuhn and Durum (53) 
postulated the presence of a specific antibody response 
to a particular product of the trypanosome that may be 
important in immunity. Koeberle (51) has postulated 
that trypanosomes invade cells by secreting a lytic enzyme. 
An antibody to such a product was suggested by Kuhn and 
Durum to explain the disparity between high parasitemias 
and survival of adoptively immunized mice. They reasoned 
that circulating antibody to such a factor could limit 
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cell invasion and cause an accumulation of parasites in 
the blood, resulting in "increased longevity and an 
increase in parasitemia in these immune manipulated mice." 
They suggested that increased longevity could be due to 
decreased tissue damage since fewer cells are invaded 
and destroyed. The weakness of this argument, aside from 
the fact that no such lytic product or antibody to such 
a product has been found, is that T. cruzi has never been 
observed to multiply outside of host cells. Since Kuhn 
and Durum observed an increase of over 100 fold in the 
number of parasites from the challenge dose to the peak 
of parasitemia, cell invasion apparently occurs. Also, 
there has been consistent failure in attempts to transfer 
protection with serum from infected animals. In summary, 
there have been a number of indications that parasitemia 
levels are not good indices of pathological state. There 
apparently is more than the activated macrophage involved 
in the immune status of the experimental animal, since 
the phagocytes would seemingly tend to decrease the numbers 
of extracellular forms rather than to allow them to increase. 
However, in the present study involving protection with 
live, attenuated organisms, specifically activated macro­
phages probably play a very important role in protection. 
High numbers of parasites did not develop in immunized 
mice, and macrophages from acutely ill animals were observed 
to appear activated when cultured ̂  vitro. 
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This observation indicates that the RES may be stimu­
lated during acute Chagas' disease. Peritoneal exudate 
cells removed from mice 15 days after infection with one 
LD^Q dose appeared larger than peritoneal exudate cells 
from normal animals, with more and larger pseudopodia 
(personal observation). Infected mice show an increased 
ability to clear colloidal carbon from the blood stream 
(Fig. 1, Table 5). Similar reports have been made by 
Clinton e_t a2. (15) . Associating increased carbon clear­
ance with an increase in the activity of individual 
phagocytes may not be entirely correct. This study 
shows that a dramatic increase in spleen size occurs in 
infected animals, beginning on about day seven or eight 
after infection with one dose (Fig. 2, Table 6). 
Increased carbon clearance could be merely a function of 
the relatively huge spleen possessed by these mice. The 
rate of carbon clearance and course of changes in spleen 
size in immunized, infected animals is not known. This 
information might be very useful in interpreting the mode 
of action of the live trypanosome vaccine. 
Of possible significance along these lines are the 
observations by Grogan (33) that treating animals with 
anti-thymocyte serum (ATS) did not decrease their phago­
cytic activity as measured by carbon clearance. This 
indicates that immunosuppressed animals can show normal 
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abilities to phagocytose, a situation somewhat analogous 
to that existing in mice acutely infected with T. cruzi. 
Immunosuppression in Experimental 
Chagas' Disease 
Studies were undertaken to determine the effects of 
acute infection with T. cruzi on the immune response of 
mice to antigens unrelated to those of the parasite. It 
was found that acute parasitemia was accompanied by pro^ 
nounced alterations in the immune responses of the un­
protected host. In all cases, there were direct correla­
tions between the degree of parasitemia and the degree of 
immunosuppression. Responses in mice to various antigens 
were found to be decreased as the infection progressed. 
Various physical changes that accompanied the infection 
were also studied. 
Within eight days following ip challenge with one 
LDgQ dose of virulent trypanosomes, the organisms could 
be seen in the peripheral circulation. After that time, 
the numbers rose logarithmically until death of the host 
on about the eighteenth day following infection (Fig. 3, 
Table 7). Accompanying this rise in parasitemia was a 
corresponding increase in spleen size (Fig. 2, Table 6). 
Alterations in blood counts were noted in mice as 
the infection progresses. Marked anemia occurred by the 
twelfth day of infection. 
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Leucopenia was noted by the sixteenth day after 
infection. Differential counts indicated that the major 
populations of white blood cells were depressed, without 
one population being severely depleted over the others. 
This would correspond to the observations of Taliaferro 
and Pizzi (90) who noted lymphocyte depletion in the 
spleen. It does not appear that the observed immuno­
suppression can be wholly attributed to lymphocyte deple­
tion, especially since infected animals have been shown 
to mount a good immune response against T. cruzi antigens 
(99). Also, a good inflammatory response was produced in 
infected mice following application of an alive oil-
turpentine mixture (Table 8). Measurable induration and 
erythema appeared in normal and acutely infected mice 
by 24 hours after application of the irritant. This 
suggests that the observed suppression of response to 
certain antigens involves a rather specific mechanism 
directed against cells of the immune system rather than a 
non-specific depression of white blood cell populations. 
The slightly lowered inflammatory response in infected 
animals is probably due to the decrease in circulating 
leukocytes that accompanies infection. 
Mice showed a decrease in their primary response to 
SRBC and LPS during the terminal stages of infection when 
parasitemia was at its peak. The antibody levels were 
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measured by passive hemagglutination procedures. It would 
probably have been better to use a more sensitive method 
such as assaying for numbers of plaque-forming cells, so 
that sharper distinctions between antibody levels could 
have been made. 
Depression of the immune response to heterologous 
erythrocytes has been noted before in animals with para­
sitic infections. Clinton (15) observed a depression of 
antibody to burro erythrocytes in mice during the acute 
stages of infection with a "myo- and reticulotropic strain 
of T. cruzi." Numbers of plaque-forming cells were 
assayed during the primary response to the erythrocytes. 
Their results closely paralleled those obtained in this 
study. In both studies, it was found that infected mice 
not given erythrocytes had negligible amounts of non­
specific agglutinins in their serum. 
Perhaps the parasitic disease most often associated 
with immunosuppression is malaria. Wedderburn (103) 
observed a reduced number of hemolytic plaque-forming 
cells in the spleens of mice infected with Plasmodium 
berghei yoelli and given SRBC. These animals were in­
fected with a non-pathogenic Plasmodium that produces a 
high parasitemia but is a self-limiting disease. It is 
probable that a different mechanism is at work in this 
system than in acute Chagas' disease, a rapidly fatal 
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infection. Also, the malaria parasite infects red blood 
cells rather than cells of the reticuloendothelial 
system. However, like Chagas' disease, the peak of 
immunosuppression corresponds to the peak of parasitemia. 
Malarial-induced immunosuppression has been demon­
strated using a variety of antigens including heterolo­
gous RBC (5, 29, 30, 77, 83), human gamma globulin (29), 
Salmonella typhimurium (45), and certain viruses (77). 
However, responses to human serum albumin, Keyhole limpet 
hemocyanin (KLH), and bacteriophage ^ x 174 are reportedly 
normal in mice with malarial infections (5, 29, 30, 101). 
These results indicate that responses to T-cell 
independent antigens are normal, while those to T-cell 
dependent antigens are depressed. Presumably, many of 
the T-cell independent antigens, such as bacteriophage, 
KLH, and LPS, do not require macrophage processing or 
T-cell cooperation for antibodies to be produced. In con­
trast, T-cell dependent antigens, such as erythrocytes, do 
require macrophage processing and T-cell-B-cell interaction 
for the production of antibodies. These findings concern­
ing malarial immunosuppression suggest a defective immune 
mechanism at the T-cell or macrophage level. Further, it 
has been noted that P. berghei infection has no suppress­
ive effect on an already established response to SRBC, 
and that malarial antibodies are produced at the time of 
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maximal immunosuppression. These findings suggest that 
there is not a non-specific inhibition of immunoglobulin 
synthesis (29, 30). 
No other reports of the effects of infection with 
T. cruzi on antibody response to T-cell independent anti­
gens are available. This study indicates that the re­
sponse to dLPS, an antigen not requiring T-cell processing 
(102), is depressed during infection. Here again it would 
be of interest to perform more sensitive tests for anti­
body levels. 
Although decreasedresponse to SRBC may indicate a 
T-cell or macrophage involvement, a reduced response to 
dLPS cannot be explained in these terms. It does not 
seem likely that a decrease in immunoglobulin synthesis 
occurs since trypanosomal antibodies are produced during 
acute infection. However, lymphocyte depletion in the 
spleen and lymph nodes does occur. Perhaps this prevents 
de novo immunoglobulin synthesis to an antigen administered 
when the trypanosomal antigen is already present in high 
amounts. 
An interesting observation was made by Perkins and 
Makinodan (71) who have shown ̂  vitro that an excess of 
macrophages has an inhibitory effect on the SRBC response. 
Presumably, increased macrophage activity removes the 
antigen making it less accessible to the lymphocyte 
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populations. However, it would seem that increased 
uptake of antigen processing by macrophages is required 
for antibody production against erythrocytes. Never­
theless, consistent observations associate increased 
macrophage activity with decreased antibody production. 
As mentioned earlier, mice with acute T. cruzi infec­
tion appear to have activated macrophages. Perhaps 
increased phagocytosis of parasites affects antibody 
production to SRBC in infected mice. However, such an 
explanation is not sufficient to explain a decreased 
response to dLPS if macrophage processing is not re­
quired by plasma cells to produce antibodies against 
endotoxin. 
This study demonstrates that a significant depression 
of the cellular immune response develops in mice suffer­
ing from acute infection with T. cruzi. Groups of mice 
were immunized with CFA and challenged with T. cruzi 
on the same day or on the fourth or ninth day after 
immunization. Animals tested five days after infection 
responded as well as did the normal sensitized mice but 
animals tested 14 days after infection with T. cruzi 
had markedly reduced delayed hypersensitivity reactions. 
Animals sensitized with CFA on the fourth day after 
infection and tested on the eighteenth day of infection 
failed to express delayed hypersensitivity. It is 
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evident that as the disease progresses the animals have 
less ability to express delayed hypersensitivity. 
Studies of induction of delayed hypersensitivity 
to oxazolone in mice infected with T. cruzi appeared 
to indicate an inability to develop a delayed response 
as the disease progressed. This interpretation may be 
incorrect, however, since the tests for delayed hyper­
sensitivity were performed at least eight days after 
the animals were sensitized. This prevented sensitiza­
tion past the tenth day of the eighteen day duration 
of the disease. The disease had progressed to a marked 
extent by the time of skin test in the animals sensitized 
four or eight days after infection. 
Animals sensitized with oxazolone, skin tested, and 
infected two days later, were skin tested again at various 
days after infection. By the twelfth or fourteenth day 
of infection the animals were unable to express a delayed 
response. These data indicate that the efferent rather 
than the afferent arm of the response is suppressed. 
Immunosuppression during acute Chagas' disease has 
been previously reported. Clinton et (15) observed 
a lowered antibody response to burro erythrocytes in 
mice infected with a "myo- and reticulo-tropic strain" 
of T. cruzi. Observations made by these workers, also 
supported by our own observations, indicated that 
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an increased phagocytic and cytolytic activity of macro­
phages occurred in infected animals. 
Many other protozoal infections are associated 
with immunosuppressive effects. Mansfield and Wallace 
(59) noted a decreased response to CFA in rabbits chron­
ically infected with T. congolense. The rabbits were 
immunized with CFA after infection in these experiments. 
Decreased antibody production to sheep red blood cells 
Occurred in mice infected with Plasmodium berghei yoelii 
(29), but their response to oxazolone was not affected, 
even during peak parasitemia. In this instance, mice 
develop an acute but non fatal disease. Other workers 
have observed immunosuppression in malarial infections 
(31, 77), including depression of certain antibody 
responses in children with malaria. A diminished anti­
body response to ovalbumin in hamsters infected with 
Leishmania donovani has been observed by Clinton et aJL (14) . 
Inasmuch as oxazolone sensitivity is an indicator 
of a cell-mediated response (4, 96, 97), the failure of 
animals to respond to eliciting doses of this substance 
indicates an involvement of the macrophage and/or the 
thymus-dependent lymphocyte populations. The histological 
appearance of contact sensitivity reactions is character­
ized by an abundance of these cell types (97). Spleen 
damage and lymphocyte depletion is found in mice infected 
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with T. cruzi (90, 92) and depressed lymphoid cell popu­
lations have been reported in animals with Toxoplasma 
gondii infections (39, 43). Thus lymphocyte depletion 
may be thé key to the observed immunosuppressive effects 
in acute Chagas' disease. However, if it is the efferent 
arm of the response that is depressed, as these results 
indicate, alteration of macrophage function may be re­
sponsible for immunosuppression. 
The Tulahuen strain of T. cruzi is reticulotropic, 
showing a preference for macrophages as the host cell. 
Although the macrophage may be functioning normally in 
phagocytosis (15), harboring the parasite might in some 
way interfere with the receptor sites on the cell surface 
that interact with T-lymphocytes in cellular responses. 
The T-lymphocyte itself may be the key to the immuno­
suppressive effects, since this cell is involved in 
cellular responses and is required for production of 
antibodies to erythrocytes. However, a similar argument 
may be made for implicating the macrophage as the primary 
cell involved. Infection of the macrophage may affect 
the macrophage-T-cell interaction, or might interfere 
with processing of the test antigen by the macrophage. 
Although the response to oxazolone in mice acutely 
infected with malaria is not depressed, there is evidence 
that cell-mediated immunity may be depressed in such 
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animals. Sengers ̂  aj.. , (83), observed that infected 
mice were unable to develop cell-mediated immunity 
against a skin heterograft. Observations of this type of 
immunosuppression in malaria is rare, however. It seems 
that there are different mechanisms involved in malarial 
and American trypanosomal-induced immunosuppression. 
Loose et al. (56) has called malarial immunosuppression 
a macrophage mediated defect. This suggestion is based on 
the observation that macrophages from infected mice showed 
decreased capability to invoke antibody formation when 
transferred to syngeneic recipients. The macrophages 
were first allowed to phagocytose heterologous erythro­
cytes ̂  vitro, then passed to normal and infected re­
cipients. Macrophages from mice with malaria were appar­
ently less effective at processing and/or presenting the 
antigen for the production of an immune response. The 
authors concluded that malaria was immunosuppressive 
through action on the macrophage by interfering with anti­
gen processing. This would indicate that the inductive 
phase of the immune response is interrupted, in that the 
T-cells are not stimulated by macrophage-associated antigen. 
To determine whether the depressed cellular response 
during T. cruzi infection was directed toward the induction 
or expression of delayed hypersensitivity, several experi­
ments were done using oxazolone as the test antigen. 
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Oxazolone is a hapten that binds to epithelial proteins 
to become antigenic. It invokes a good cell-mediated 
response when applied to the skin and is convenient for 
rapid sensitization and easy elicitation. 
Administration of oxazolone to the skin produces 
rapid proliferation of lymphocytes in draining lymph 
nodes (97). This process is part of the induction of a 
cellular immune response. Three to four days following 
sensitization with oxazolone, draining lymph nodes contain 
large numbers of lymphoblasts. These are relatively 
large cells, rich in RNA. These cells are able to trans­
fer sensitivity to oxazolone when injected into syngeneic 
animals (4). Several experiments were done in the present 
study to determine whether lymphoblasts were formed 
following oxazolone administration in an infected mouse. 
Since formation of these lymphoblasts following antigenic 
stimulation indicates the induction of an immune response, 
their presence or absence in an infected animal would in­
dicate whether or not this phase of the response was being 
interfered with. 
Quantification of lymphoblasts in sensitized infected 
mice is difficult, since the infectious process alone leads 
to adenopathy and increased numbers of large dividing 
cells in the lymph nodes. However, by comparing draining 
lymph nodes from infected mice, both sensitized with 
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oxazolone and unsensitized, it was found that there 
were proportionally more lymphoblasts in the sensitized 
animals. Furthermore, cells from draining nodes of 
sensitized infected mice were able to transfer contact 
sensitivity to normal mice (Table 13). 
It is also of interest to note that in infected 
animals not sensitized with oxazolone, lymphoblast^like 
cells appear in both the cortical and paracortical 
regions. However in mice sensitized with oxazolone, the 
paracortical areas and not the cortex show large numbers 
of lymphoblasts. This observation made it easier to 
assess the induction of contact sensitivity in infected 
mice. The results obtained from histological observations 
and cell transfer studies indicate that induction of 
contact sensitivity does occur in infected mice, as 
measured by the ability of lymphocytes to become sensi­
tized following administration of oxazolone. No experi­
ments of this nature have been reported in association 
with immunosuppression in other diseases. It would be 
of interest to determine whether induction of the immune 
response occurs in other parasitic diseases that lead to 
immunosuppression. 
To further examine whether the afferent or efferent 
arm of the immune response was interfered with, a series 
of cell transfer studies was undertaken. 
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A primary criterion for the existence of cell-
mediated immunity is whether or not the immunity or sensi­
tivity can be passively transfered with sensitized T-lympho-
cytes. To demonstrate the nature of the response to oxazo-
lone, transfers of different populations of lymphocytes 
from sensitized to normal mice were made (Table 10). By 
using a nylon wool column, spleen cells from sensitized 
mice were divided into three groups; a B-cell enriched 
population, a T-cell enriched population, and a mixture 
of the two. Macrophages are nearly all eliminated from 
the preparation by the nylon column. The three prepara­
tions were injected into syngeneic recipients which were 
skin tested 48 hours later and read 24 hours after skin 
test. The results confirmed the cell-mediated nature of 
the response to oxazolone. The T-cell enriched populations 
transferred sensitivity much more effectively than the 
B-cell enriched populations. 
Asherson & Ptak (4) showed that contact sensitivity 
was more effectively transferred with peritoneal exudate 
cells than with lymph node cells, although both types 
were effective. This observation has been confirmed in 
our laboratory. This is probably due to the presence of 
large numbers of macrophages in the peritoneal cell prep­
arations. The macrophages are already primed to the 
oxazolone, so when they are transferred along with sensi­
tized T-cells, all the requirements for expressing a 
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delayed hypersensitivity response are met. If only the 
lymphocytes are transferred, it is best to wait 24 to 
48 hours before skin testing to allow the sensitized 
T-cells to interact with the recipient's macrophages. 
It cannot be reasonably argued that this delay produces 
active sensitization rather than passive transfer, for at 
least four to five days are required to bring about 
active sensitization to oxazolone (97) 
Contact sensitivity was readily transferred from 
infected to normal mice, even though the infected animals 
were unable to respond to the agent. The sensitivity 
was successfully transferred even when the donor mice 
were in the final days of infection, at the height of 
immunosuppression. These experiments indicate that the 
infected mice, although unable to respond to oxazolone, 
have sensitized T-cells. 
One shortcoming of the spleen cell transfer experi­
ments results from the limited number of days animals 
can be sensitized with oxazolone following infection. 
Since the mice usually die by eighteen days after infection, 
and because about six days are required to obtain sensi­
tized spleen cells following oxazolone application, it 
is not possible to sensitize animals in this manner when 
they are in the peak infection period. Oxazolone must be 
applied to the abdomen by-the eleventh or twelfth day 
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after infection to allow the spleen cells to become 
sensitized before the mice succumb. As seen earlier, 
the peak period of immunosuppression occurs between days 
14-18. 
To overcome this problem, the experiment mentioned 
earlier was performed. Mice were sensitized by apply­
ing oxazolone to both ears during the period of peak 
parasitemia (Table 13). The successful transfer of 
sensitivity with lymph node cells indicates that mice 
are able to become sensitized to oxazolone during the 
height of immunosuppression. 
Based on these observations, it was postulated that 
the immunosuppression might be due to a macrophage defect. 
The first approach to examine this possibility was to 
administer normal peritoneal exudate cells, which had 
been adhered to glass, to infected sensitized mice immedi­
ately before applying the eliciting dose of oxazolone to 
the ear. The addition of normal macrophages to infected 
animals prior to skin testing improved their response 
significantly. This indicates that perhaps a deficiency 
of available macrophages in the infected mice could explain 
the immunosuppression. Since there doesn't seem to be a 
significant drop in any single circulating leukocyte 
population during acute infection (Fig. 6), and there is 
an increased clearance rate of colloidal carbon in infected 
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mice (Table 5), a decrease in macrophage number is probably 
not responsible. However, the macrophages may be unable 
to respond to an antigen such as oxazolone, possibly due 
to the large numbers that are infected with parasites. 
The presence of many parasites, both inside and outside 
of macrophages, may interfere with the ability of the 
macrophage to recognize and respond to another antigen. 
Evidence against this possibility comes from the observa­
tion that mice immunized with attenuated trypanosomes 
and infected with virulent forms respond well to oxazolone 
(Fig. 10). This might provide an argument against antigenic 
competition, since much antigen is present in the immunized, 
infected mice. However, extensive parasite invasion of 
macrophages and high parasitemia does not occur when 
specifically immunized mice are infected. It could be 
the intracellular presence of the virulent parasites that 
is chiefly responsible for the failures of the immune 
response to other antigens. 
Potentiation of Bacterial Lipopolysaccharide (LPS) 
Toxicity in Mice Infected with T. cruzi 
When studying the antibody response to bacterial 
LPS in infected mice, it was noted that many of the animals 
died suddenly, often within fifteen minutes, after receiv­
ing an iv injection of the endotoxin. Subsequently, 
detoxified endotoxin was used for antibody assays. The 
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degree to which the toxicity of LPS was potentiated was 
quantitated in further experiments. 
Mice in the acute stages of infection with T. cruzi 
were found to die of what appeared to be toxemia or endo­
toxin shock when given iv injections of very small amounts 
of LPS. Death generally occurred within twelve hours 
or less after the mice received the endotoxin. In mice 
near the terminal stages of infection, deaths occurred 
in one hour or less. In general, mice infected the 
longest were most susceptible to injection of endotoxin 
(Table 14). Whereas 200 pg or more are usually required 
to kill a normal RML adult mouse (personal observation), 
as little as 0.1 yg was toxic to acutely infected mice. 
It is difficult to suggest a mechanism to explain 
the potentiation of LPS toxicity, since the mode of action 
of LPS is not clearly understood. Filkens (23) observed 
that sonicates of rat peritoneal, alveolar, and hepatic 
macrophages detoxified endotoxin from Salmonella enteriditis, 
and he suggested that macrophage lysosomes were important 
in the detoxification of LPS. Evans and Alexander (21) 
have reported that endotoxin activates peritoneal exudate 
cells so that they non-specifically kill target cells. 
In addition, Gery and Waksman (24) haVe reported that 
macrophages treated with endotoxin release a soluble 
factor that stimulates T-lymphocytes. It is apparent that 
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LPS effects macrophages, which in turn can presumably 
detoxify LPS. 
Studies on the relationship between endotoxin and 
the RES have indicated that the liver and spleen are the 
major organs responsible for the removal of endotoxin 
from the blood (20) and its subsequent detoxification 
(94). Stimulation of the RES by BCG or glucan has been 
shown to increase sensitivity to endotoxin (18, 89). 
In addition. Loose et a2., (55) found increased toxicity 
of endotoxin in mice infected with Plasmodium berghei; 
a 41-fold increase was reported. They gave iv injections 
of from 2 00-500 yg of endotoxin, much higher doses than 
found necessary to kill mice infected with T. cruzi. 
In malaria, as in T. cruzi infections, there appears 
to be stimulation of the RES (16, 50). In the studies 
of Loose et (55) it was concluded that the ability 
to detoxify LPS was reduced in infected mice. Evidence 
indicates that activation of the RES has an effect on the 
lysosomes, preventing them from detoxifying the LPS. 
This effect could be due to depletion of lysosomal contents 
upon activation, possibly resulting from the presence of 
intracellular parasites. 
In view of the apparent stimulation of the RES 
during T. cruzi infection, it seems more likely that 
failure to detoxify endotoxin, rather than failure to 
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phagocytose it might explain the increased susceptibility 
to LPS at the macrophage level. We have observed that 
agents that block RES activity, such as colloidal carbon 
and silica also potentiate LPS toxicity in mice. Lysosomal 
depletion could explain these situations as well. Although 
the RES is not activated by such agents, they act to fill 
the phagocytes with particles, as with carbon, or to 
rupture them, as with silica. Both situations cause 
release of lysosomal contents. 
The presence of very large numbers of circulating 
trypanosomes can deprive the host of a tremendous amount 
of glucose. The parasites are extremely active, and they 
use serum glucose in their metabolism. Several workers 
have reported that blood glucose concentrations fall to 
below a fasting level subsequent to administration of 
endotoxin (84). Cumulative effects of infection and 
endotoxin could cause hypoglycemic shock. Shands et al. 
(84) tested for this by administering glucose to infected 
animals, but they had variable results and were not able 
to draw any definite conclusions. 
Chapter 5 
SUMMARY 
Resistance to Trypanosoma cruzi in mice is cell-
mediated and requires specific activation of the immune 
system. Several lines of evidence support this hypo­
thesis. 1) BCG alone does not protect against acute 
infection. 2) Live preparations of attenuated trypano-
somes provide good protection whereas killed organisms 
do not. 3) To obtain protection, live preparations 
must be administered at least 12-14 days in advance of 
challenge. 4) Administration of silica particles, a 
macrophage toxin, prior to challenge exacerbates infection. 
Activation of the immune system with BCG not only fails 
to confer immunity to T. cruzi, but actually interferes 
with induction of specific resistance by attenuated 
trypanosomes. Mice sensitized with BCG prior to immuni­
zation with attenuated trypanosomes were not protected 
by the immunization procedure as well as normal mice. 
Although the phagocytic system is apparently activated 
in mice infected with T. cr'uzi, and the inflammatory 
response appears to be largely unaffected, the ability 
of infected animals to mount a response against antigens 
other than those of the trypanosome is decreased. Mice 
infected with T. cruzi and sensitized with heterologous 
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erythrocytes at various intervals after infection lost 
their ability to produce antibodies as the infection 
progressed. Similarly, there was a decrease in the 
animals' response to detoxified bacterial lipopoly-
saccharide during the latter stages of infection. 
The effect of acute infection on the cellular immune 
response was also studied. Mice were immunized with 
either Freund's complete adjuvant or oxazolone, a chemi­
cal sensitizing agent, and were subsequently skin tested 
with either BCG protoplasm or oxazolone to detect delayed 
hypersensitivity. Depression of the response to these 
antigens was observed in infected mice during the stage 
of marked parasitemia. Mice which were responsive to 
oxazolone before infection lost their ability to respond 
as the infection progressed. When immunized with live 
attenuated T. cruzi, mice developed a greater than normal 
sensitivity to oxazolone and survived infection. Infected 
mice unable to respond to oxazolone were capable of 
conferring sensitivity to this substance in normal 
syngeneic mice via spleen cell transfer. The ability of 
infected mice to respond to oxazolone was significantly 
improved when macrophages from normal syngeneic donors 
were administered at the time of skin test. When normal 
and infected mice were used as recipients of lymphocytes 
from syngeneic oxazolone-sensitized donors, the normal 
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mice responded significantly better than did the infected 
mice. These results indicate that immunosuppression 
due to infection with T. cruzi is directed toward expression 
rather than induction of the cell-mediated immune response 
to the antigens employed. 
Decrease in the capability of the immune response 
of infected mice was also shown by their increased sus­
ceptibility to the toxic effects of bacterial lipopoly-
saccharide. Mice became increasingly susceptible to 
minute quantities of the toxin as the infection progressed, 
leading to death shortly after administration of the 
substance. 
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APPENDIX 
Bouin's fixative 
Picric acid (saturated aqueous, filtered) 75 ml 
Neutral formalin (filtered) 
2 0 g sodium acetate plus 100 ml 4 0% formalin 25 ml 
Glacial acetic acid 5 ml 
Giemsa stain for mouse blood cells 
Stock giemsa: 1. Dissolve 0.5 g giemsa powder in 33 ml 
glycerine. 
2. Heat at 55-60°C for 1 1/2 to 2 h. 
3. Add 33 ml absolute methanol. 
0.15.M phosphate buffered saline pH 6.4 (PBS): 
0.85% saline 100 ml 
0.15 M Na^HPO^ 32.2 ml 
0.15 M KH2PO4 67.8 ml 
1. Fix smears in absolute methanol for 10 seconds or longer. 
2. Allow slides to air dry. 
3. Rinse a small test tube with 5 ml distilled water and 
add another 5 ml distilled water to the tube. Add a 
few crystals of hematoxylin to the test tube. If the 
water appears yellow the pH must be adjusted. Add 
about 0.1 ml 1% KCO3/200 ml distilled water. The color 
of the water in the 5 ml tube should be light pink in 
color when hematoxylin is added. 
4. Use 0.2 ml stock giemsa/ml PBS pH 6.4. Flood smear 
with 3 ml/slide for 30 seconds. 
5. FJpat off stain with adjusted distilled water. 
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Turk's white blood cell diluting fluid 
Glacial acetic acid 2 ml 
Aqueous gentian violet 1% w/v 1 ml 
Distilled water 100 ml 
Mix and filter 
